Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7733930557799669,1.878938971223598,0.0,0.08705966838075942,0.078,6/21,13.21%,FGF20;FGF9;FGF10;FRS2;KL;NPTN
prerank,anion transmembrane transporter activity (GO:0008509),-0.6820321371362589,-1.7888602766999626,0.0,0.8756106467860514,0.458,5/12,12.10%,ABCG2;SLC39A8;SLC22A6;SLC26A11;SLC4A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7639078597151799,1.7763693892421928,0.0013422818791946308,0.33185647785999156,0.464,1/15,0.14%,PLA2G5
prerank,diacylglycerol kinase activity (GO:0004143),-0.6664341000590711,-1.7203488958366815,0.009146341463414634,0.8601076254194429,0.703,7/11,12.04%,DGKH;AGK;DGKB;DGKE;DGKZ;DGKD;DGKG
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.8023631190008428,1.6882858638531117,0.009036144578313253,0.8153652812864672,0.88,1/10,0.02%,DPYSL4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5834864756070636,1.6805728143234318,0.0,0.6735422731178108,0.898,11/73,11.05%,FSHR;S1PR2;LTB4R2;VIPR2;OPRK1;HCRTR2;GPR37;BDKRB2;LGR4;PTH1R;HCRTR1
prerank,phosphatidate phosphatase activity (GO:0008195),0.7702315338415661,1.6803056806520758,0.007204610951008645,0.5397699439607084,0.899,8/13,15.83%,LPIN1;PLPPR2;LPIN3;LPIN2;PLPP3;PLPPR5;PLPP4;PLPP5
prerank,solute:sodium symporter activity (GO:0015370),0.6584614605219765,1.6729566234154198,0.0025252525252525255,0.49427424629076316,0.921,4/27,5.03%,SLC4A4;SLC4A5;SLC5A3;SLC20A2
prerank,hormone activity (GO:0005179),0.5964424906257121,1.6688224132924374,0.005537098560354375,0.4465318475013144,0.929,5/54,3.71%,APLN;IGF1;EDN3;GNRH1;PTHLH
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.6815940452068544,1.664249428947912,0.005115089514066497,0.4127143150254549,0.94,9/22,12.39%,ILF3;CPEB1;KHSRP;ZFP36L1;EXOSC8;RBMS3;DHX36;NUDT21;HNRNPA0
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6658789738706026,-1.6641580310301083,0.016853932584269662,0.9359690766400474,0.886,4/10,11.65%,SLCO3A1;SLCO1C1;SLCO2A1;SLC22A6
prerank,filamin binding (GO:0031005),0.7787029781351595,1.659851352742302,0.002894356005788712,0.38828404069937267,0.947,1/11,0.02%,DPYSL4
prerank,CXCR chemokine receptor binding (GO:0045236),0.7889505678362836,1.654514798419876,0.01669195751138088,0.37267154819763787,0.959,2/11,4.50%,YARS1;CXCL12
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.57736523180792,-1.6507563414604554,0.03597122302158273,0.6238415797923285,0.91,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.57736523180792,-1.6507563414604554,0.03597122302158273,0.6238415797923285,0.91,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,aspartic-type peptidase activity (GO:0070001),-0.6525594196825066,-1.642810219191916,0.017391304347826087,0.5545947510214769,0.923,3/10,8.71%,BACE2;BACE1;DDI2
prerank,exoribonuclease activity (GO:0004532),0.7450945481673765,1.6141775709421076,0.015625,0.5318894695794197,0.995,5/12,6.42%,EXOSC1;EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,C-C chemokine receptor activity (GO:0016493),0.6548570318750897,1.6107394258625714,0.019404915912031046,0.5051176996105889,0.995,3/21,7.14%,CCR9;ACKR2;CXCR4
prerank,peptide hormone receptor binding (GO:0051428),0.7585714028813528,1.6058559409496964,0.021994134897360705,0.48973763826099653,0.995,3/11,10.46%,GNRH1;PTHLH;PSMC5
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7086607492896071,1.5959959110760207,0.020718232044198894,0.5035017687458667,0.998,3/14,8.40%,RDH10;RDH11;RDH5
prerank,frizzled binding (GO:0005109),0.6000123601870337,1.5865236488096952,0.013126491646778043,0.5191751836985933,0.999,8/34,11.52%,WNT2B;WNT5A;SFRP1;DVL2;DVL1;WNT4;SDCBP;ZNRF3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5470294447746745,1.5688007067483973,0.0053533190578158455,0.5811583911465613,0.999,35/78,19.59%,SFRP1;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;CAPN10;USP24;USP47;USP42;CAPN5;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;USP40;USP9X;PIGK;CTSZ;CASP2;USP34;USP35;CTSH;USP48;CAPN15;CAPNS1;USP33;CTSK;CTSO;USP37
prerank,anion:anion antiporter activity (GO:0015301),-0.5408419451658227,-1.5659114678685493,0.03765690376569038,0.8442502492787404,0.984,8/17,28.01%,SLC26A7;SLC26A2;SLC25A4;SLC26A11;SLC4A2;SLC4A3;SLC25A11;SLC25A5
prerank,amino acid:sodium symporter activity (GO:0005283),0.7288360254657349,1.5620026451495859,0.032448377581120944,0.584142291070902,1.0,6/11,17.79%,SLC6A11;SLC1A3;SLC6A15;SLC6A12;SLC6A13;SLC1A2
prerank,protein phosphatase 2A binding (GO:0051721),-0.472646094515511,-1.560806715001445,0.024896265560165973,0.7672445274334575,0.986,8/23,8.90%,MFHAS1;DAB2IP;PPME1;CTTNBP2NL;ENSA;STRN4;SMG5;TP53
prerank,neuropeptide receptor binding (GO:0071855),0.6923376679504536,1.5590857156908855,0.019178082191780823,0.565159746889912,1.0,2/14,9.10%,APLN;NMU
prerank,cysteine-type peptidase activity (GO:0008234),0.5411296288390558,1.5500431847963356,0.010638297872340425,0.5823685796607676,1.0,34/73,19.59%,OTULINL;SFRP1;ATG4A;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;USP24;USP47;USP42;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;GGH;USP40;USP9X;CTSZ;CASP2;USP34;USP35;CTSH;USP48;USP33;CTSK;CTSO;USP50;USP37
prerank,hexosyltransferase activity (GO:0016758),0.5232829060109554,1.543475907231709,0.002081165452653486,0.5873719239301882,1.0,22/101,12.71%,ALG5;B3GALNT1;TMTC4;A4GALT;B3GLCT;ALG6;GBA2;CHPF;OGT;PIGM;MGAT4B;ALG1;TMTC1;POMGNT1;CHSY3;MGAT4C;POMT2;GBE1;DPY19L1;DPY19L3;ALG9;B4GALT5
prerank,C-C chemokine binding (GO:0019957),0.6243776530634382,1.542448386838008,0.029947916666666668,0.5639041500341048,1.0,3/22,7.14%,CCR9;ACKR2;CXCR4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5391869440535328,-1.539498510851987,0.0625,0.7834193463926192,0.993,7/15,22.35%,COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1;COX15
prerank,vinculin binding (GO:0017166),-0.6060172665837983,-1.5360550904690804,0.04643962848297214,0.7208284814618316,0.995,5/11,6.84%,UTRN;SORBS3;PXN;ACTN1;DMD
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7304012241742535,1.534888258070561,0.028694404591104734,0.5781425778540461,1.0,2/11,4.12%,SLC17A5;SLC5A3
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6986275057559281,1.524935891277091,0.03508771929824561,0.6029462026145723,1.0,6/12,10.08%,IGF1;PIK3R1;ARRB1;YWHAH;GNAS;YWHAG
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.7367345004536159,1.5244558924552598,0.03142857142857143,0.5800077369273712,1.0,2/10,0.62%,CDKN2D;HEXIM1
prerank,calcium channel inhibitor activity (GO:0019855),0.7109662168699755,1.5157917866113058,0.038011695906432746,0.6020784550082713,1.0,4/11,9.62%,TNNI3;ITPR1;PACSIN3;SLC30A1
prerank,mannosyltransferase activity (GO:0000030),0.6084171064600653,1.5065867357048937,0.05026455026455026,0.6269880335742534,1.0,12/21,21.09%,TMTC4;PIGM;ALG1;ALG8;TMTC1;POMT2;DPY19L1;DPY19L3;ALG9;DPM1;DPY19L4;PIGB
prerank,poly(A) binding (GO:0008143),0.6222802982323368,1.5055033486100151,0.03230148048452221,0.6091749794703079,1.0,10/21,15.96%,DDX3X;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL
prerank,dynactin binding (GO:0034452),0.6858089633959212,1.5024123560857112,0.041428571428571426,0.6035668944999424,1.0,7/12,13.92%,SPTBN5;SNX5;SNX6;HOOK3;BICDL1;HTT;MAPT
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5434986061686699,-1.4908895244436746,0.06115107913669065,0.8742576558304201,1.0,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6555218449571343,1.4888085638844086,0.04938271604938271,0.6519306869179894,1.0,2/15,3.24%,CCR9;ACKR2
prerank,symporter activity (GO:0015293),0.7028323244506934,1.4843189649289643,0.06259541984732825,0.6548821721530459,1.0,1/10,0.31%,SLC4A4
prerank,chemokine receptor activity (GO:0004950),0.589287931091766,1.4820172580222875,0.0440251572327044,0.6463493381969387,1.0,3/24,7.14%,CCR9;ACKR2;CXCR4
prerank,cadherin binding (GO:0045296),-0.27023983021944453,-1.4800244209794953,0.0,0.8533896494939125,1.0,110/315,17.70%,NIBAN2;WASF2;COBLL1;PTPRB;CD2AP;CAST;DAB2IP;PICALM;EXOC3;CTNNA3;RDX;EGFR;CD46;EIF3E;PPME1;BAIAP2L1;DOCK9;YWHAZ;VAPA;EPS15L1;ITGA6;FLNA;MARK2;ARHGAP18;MB21D2;PARVA;MAPRE1;EIF2A;BSG;PTPRM;PDLIM5;BAG3;TJP1;SWAP70;STAT1;SLC3A2;PKP4;CEMIP2;CTTN;NOTCH3;UBAP2;CDH6;HSP90AB1;NCK1;TRIM25;ANLN;NUMB;EZR;ERC1;ARVCF;SNX2;EEF2;USP8;ACVR1;RPL6;RPL24;CDH1;IDH1;CNN2;F11R;PROM1;PLCB3;PACSIN2;LRRFIP1;EHD4;GLOD4;EPN2;CHMP5;RAB1A;PLEC;ARHGAP1;KDR;TBC1D10A;GIGYF2;RPL34;RARS1;VASP;PKM;SLK;EPS15;PTPRO;RANGAP1;TRPC4;FNBP1L;RPL15;RPS2;CDC42EP1;PTPRT;HCFC1;CHMP2B;GIPC1;PTPRJ;TLN1;TWF2;PFN1;ESYT2;SRC;PCBP1;DIAPH3;TAGLN2;ARFIP2;RPS26;ATIC;UBFD1;ALDOA;EIF5;TWF1;EEF1D;HSPA5;RPL7A
prerank,metalloendopeptidase activity (GO:0004222),0.5064078370354631,1.477768281875841,0.01167728237791932,0.6472137443736296,1.0,13/76,10.62%,ADAMTSL2;MMP12;MMP17;MMP11;ADAMTS7;NRDC;ADAMTS10;ADAMTS20;THOP1;ADAMTS5;ADAMTS6;ADAM33;AFG3L2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.44608356228514456,-1.4728665717141227,0.05319148936170213,0.8197043666578507,1.0,7/28,11.99%,DAB2IP;CASP8AP2;STAT1;RIPK1;FEM1B;TRAP1;MADD
prerank,phosphatase activity (GO:0016791),0.5017798475758263,1.4641816730005515,0.02545068928950159,0.7022359370367218,1.0,24/73,16.21%,DUSP28;DUSP18;DUSP26;APTX;ENOPH1;PTPMT1;LPIN1;HDDC2;ATP1A2;PLPPR2;LPIN3;PRUNE1;PPP1CC;HDHD2;LPIN2;PLPP3;PTPN22;PLPPR5;EPHX2;PPP5C;SACM1L;PLPP4;PLPP5;NUDT16L1
prerank,rRNA binding (GO:0019843),-0.3860072646248017,-1.4618646840111866,0.014184397163120567,0.8073087640794503,1.0,30/42,37.35%,CAVIN1;RPL11;MRPS27;RPL5;PTCD3;RPS13;DDX21;RPLP0;ERI1;RPS5;RPL12;MRPS18A;MRPS18C;FASTKD2;NOP53;MTERF4;RPF2;RPS14;ERAL1;EMG1;NGRN;MRPS7;MRPL18;UTP23;MRPL16;MRPS11;RRS1;PPAN;GTF3A;RPL23
prerank,transaminase activity (GO:0008483),0.6800766758340466,1.4475821779214384,0.07216494845360824,0.7725788408488644,1.0,4/11,8.15%,PSAT1;BCAT2;ABAT;OAT
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5440459116090337,1.4449181752443176,0.0485207100591716,0.7650819705166277,1.0,15/37,12.81%,FARSB;YARS1;WARS1;YARS2;CARS1;SARS2;GARS1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6510207142466329,1.4439249803958967,0.07391910739191074,0.7488223627122846,1.0,5/14,17.19%,CAPN10;CAPN5;CAPN2;CAPN15;CAPNS1
prerank,ribosomal large subunit binding (GO:0043023),0.6751817636686741,1.432254286354143,0.07977207977207977,0.7939355983110231,1.0,7/11,17.69%,RBM3;DHX33;NEMF;MALSU1;NPM1;MRRF;CPSF6
prerank,histone deacetylase activity (GO:0004407),0.6110090069645974,1.4262541797697754,0.08244680851063829,0.807876277554789,1.0,7/19,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;HDAC1
prerank,receptor ligand activity (GO:0048018),0.46261530241382864,1.4226749786278754,0.0,0.8071801842592163,1.0,24/245,10.19%,FGF20;SFRP2;APLN;FGF9;WNT2B;WNT5A;IGF1;IL34;EPHA7;TAFA2;BMP6;NTF3;IL33;EDN3;GNRH1;PTHLH;FGF10;WNT4;LRPAP1;TAFA5;NRG3;EGF;SEMA3D;GDNF
prerank,cation:chloride symporter activity (GO:0015377),-0.5648780647197196,-1.4222298687930073,0.09295774647887324,0.9367959044462666,1.0,6/10,27.28%,SLC12A7;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5232820704489242,1.4221356632970132,0.05730337078651685,0.7900430874187302,1.0,9/46,10.42%,B3GALNT1;B3GLCT;MGAT3;OGT;MGAT4B;POMGNT1;MGAT4C;EXTL2;PIGA
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4970913315876624,-1.417845544935643,0.09019607843137255,0.898710148622298,1.0,5/15,20.35%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,poly-purine tract binding (GO:0070717),0.5539354028941782,1.4167994295089632,0.07035175879396985,0.8022138600991299,1.0,12/27,16.78%,DDX3X;ATXN1;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL;FMR1
prerank,metallopeptidase activity (GO:0008237),0.4728415028150009,1.4119004702256133,0.017671517671517672,0.8116430681222105,1.0,21/113,11.70%,ADAMTSL2;MMP12;MMP17;MMP11;MPND;ADAMTS7;NRDC;PRPF8;ADAMTS10;ADAMTS20;ANPEP;METAP1;THOP1;ADAMTS5;LAP3;ADAMTS6;ADAM33;METAP1D;AFG3L2;ADAM12;PAPPA
prerank,ion channel inhibitor activity (GO:0008200),0.5423682781987919,1.4112047996537909,0.06565064478311841,0.7970128680719186,1.0,16/35,23.40%,TNNI3;ITPR1;PACSIN3;SLC30A1;WNK2;CAMK2D;VTI1B;RACK1;STX8;VAMP8;CALM1;SCN1B;COMMD1;CALM2;WNK3;FKBP1A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5382616962469915,1.410523629499565,0.07228915662650602,0.7827498190118573,1.0,9/32,20.20%,KCNG2;KCNA4;KCNC1;KCNC2;KCNQ4;KCNA1;KCNQ2;KCNH1;KCNA6
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5259881590511931,-1.4100482145193844,0.0880503144654088,0.8807904798073655,1.0,6/12,27.20%,SLC6A6;SLC3A2;SLC36A4;SLC38A5;SLC1A4;SLC36A1
prerank,mechanosensitive ion channel activity (GO:0008381),0.6461746133279649,1.4073195436627406,0.0784313725490196,0.7820184118923555,1.0,2/12,3.55%,TMC5;TMEM63A
prerank,NADP binding (GO:0050661),-0.3880962056659183,-1.4066910268404098,0.03954802259887006,0.8469472828371217,1.0,21/32,39.24%,LBR;ME3;CAT;CRYZL1;NOS3;DECR1;DUS2;NOX1;MTRR;CBR4;NOS1;NNT;SPR;DHFR;KCNAB1;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6526539611530195,1.4056638508574693,0.09370424597364568,0.7731989341885398,1.0,1/12,1.00%,B3GALNT1
prerank,pre-mRNA binding (GO:0036002),0.5536609563839413,1.3993791014046153,0.0821078431372549,0.7895521194879168,1.0,17/28,22.88%,TARBP2;SLBP;U2AF1;PRPF8;CELF2;CELF1;RBM41;HNRNPL;TRA2B;CELF5;DDX5;RBM22;HNRNPU;PTBP1;RBM7;U2AF2;SRSF6
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4546016544885772,-1.3980464783520652,0.06692913385826772,0.8378811884706842,1.0,6/16,12.17%,INPP5F;MTMR12;MTMR10;MTMR3;MTMR14;MTMR9
prerank,thiol-dependent deubiquitinase (GO:0004843),0.47870605712242537,1.3939948885027078,0.0288153681963714,0.8009528496257635,1.0,36/83,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,omega peptidase activity (GO:0008242),0.4745275846376478,1.3935883688437887,0.0337909186906019,0.7868612160628349,1.0,38/89,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;ASRGL1;USP2;USP11;USP15;USP3;USP19;GGH;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,voltage-gated cation channel activity (GO:0022843),0.4697315521343871,1.3910202607409867,0.03316062176165803,0.7849599261358536,1.0,19/97,15.42%,CACNA2D2;KCNG2;KCNA4;KCNC1;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;KCNMA1;KCNC2;GRIN2A;KCNQ4;CACNB1;KCND3;KCNH5;KCNA1;KCNQ2;CACNG4
prerank,vitamin D receptor binding (GO:0042809),0.6121837857019644,1.3894023196492713,0.10110803324099724,0.7784342138645639,1.0,7/14,16.84%,MED24;MED12;MED14;MED13;MED4;SNW1;THRAP3
prerank,ephrin receptor activity (GO:0005003),0.5952683154785267,1.389171439555457,0.10608203677510608,0.7502780672505374,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5952683154785267,1.389171439555457,0.10608203677510608,0.7502780672505374,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,G protein-coupled receptor binding (GO:0001664),0.46176013774209373,1.3869002245609574,0.019427402862985686,0.7478255624470729,1.0,29/132,18.06%,S1PR2;WNT2B;WNT5A;SFRP1;DVL2;TUB;ADM;STUB1;PICK1;CXCL12;DVL1;ARRB1;WNT4;PTCH1;TAFA5;GPRC5B;SDCBP;GNAS;PSMC5;GRK3;ZNRF3;USP4;TULP3;GRK2;AGTR1;USP33;GNAQ;CCL25;PACRG
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6334144020113961,1.3832318135808712,0.09502923976608187,0.7519980974386535,1.0,3/12,7.13%,NQO2;AIFM2;NDUFS7
prerank,muscle alpha-actinin binding (GO:0051371),0.6093437357577504,1.3824958902795066,0.09530386740331492,0.7422304792192971,1.0,2/15,1.71%,PDLIM2;PDLIM7
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.47261806613371704,-1.3789018078012354,0.10294117647058823,0.8753625984441857,1.0,7/14,22.07%,MTMR12;MTMR10;MTMR3;MTMR14;MTMR9;MTMR11;MTMR6
prerank,exonuclease activity (GO:0004527),0.4968725030590793,1.3691128963991819,0.08740068104426787,0.7975132044085413,1.0,15/46,17.40%,EXOSC1;EXOSC3;APLF;EXOSC7;EXOSC2;EXOSC8;ENPP2;AEN;ENPP1;CPSF3;ISG20L2;MRE11;CNOT6;RAD50;REXO1
prerank,growth factor activity (GO:0008083),0.47084911437326765,1.365893968442211,0.054140127388535034,0.7993865879796538,1.0,7/74,10.19%,FGF20;FGF9;NTF3;FGF10;NRG3;EGF;GDNF
prerank,adrenergic receptor binding (GO:0031690),0.5949951787092559,1.3636660118298605,0.09712722298221614,0.7970553018238471,1.0,5/16,14.61%,APLP1;UCHL1;GNAS;MAGI2;GRK2
prerank,P-type ion transporter activity (GO:0015662),0.6386689079675799,1.362026269491395,0.11661807580174927,0.7915876944383888,1.0,3/12,8.60%,ATP2C1;ATP2A2;ATP2B1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6483266072748296,1.3592076966273434,0.13537117903930132,0.7924225341986415,1.0,3/10,16.34%,SLC6A11;SLC6A12;SLC6A13
prerank,transcription corepressor binding (GO:0001222),0.5320558294103618,1.3563913910472962,0.1169811320754717,0.7935173208031238,1.0,9/27,16.05%,HDAC3;RORA;PHF1;EZH2;EHMT2;PER1;USP11;EHMT1;CTBP1
prerank,syntaxin binding (GO:0019905),0.4740737264500633,1.3553305190916065,0.07883369330453564,0.7854835620316956,1.0,19/61,16.55%,SYT3;SYT10;UNC13A;NAPG;STX6;ABL1;VAMP3;STX16;CPLX1;SNAP25;SCFD1;VPS54;SYT1;TMED10;DAPK1;STX8;VPS18;VAMP8;NSF
prerank,neuropeptide binding (GO:0042923),0.5756590482863702,1.353121912337534,0.11584553928095873,0.7839904511996512,1.0,4/18,17.95%,OPRK1;GPR37;GPR149;SORL1
prerank,deubiquitinase activity (GO:0101005),0.4601051282145249,1.3500993993619859,0.04246284501061571,0.7860573532211496,1.0,37/88,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;EIF3F;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.46397060134237245,-1.3465531361577674,0.13026819923371646,0.9806768373048957,1.0,6/15,10.99%,PICALM;WDFY3;EPB41;SCARB1;ZFYVE9;ZFYVE1
prerank,gated channel activity (GO:0022836),0.596868501380112,1.3449223629174663,0.13517241379310344,0.7989121670274772,1.0,2/14,3.55%,TMC5;TMEM63A
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5502495402167029,1.3428592084250282,0.12041884816753927,0.7964331916289598,1.0,8/22,16.35%,ATP2C1;ATP6V0A2;ATP2A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,receptor antagonist activity (GO:0048019),0.5650455681647308,1.3418609831453097,0.1402359108781127,0.7890849354707067,1.0,3/17,14.59%,DKK3;LRPAP1;PXDN
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6324540978196401,1.3373464330726084,0.12153846153846154,0.7992883439277014,1.0,3/11,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5924060566436248,1.3351554300817983,0.1466854724964739,0.7979132279474671,1.0,5/13,18.79%,ADH5;ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1
prerank,sodium channel regulator activity (GO:0017080),0.509326252054824,1.3324640946055406,0.0984936268829664,0.7986336866817143,1.0,13/37,21.46%,GPLD1;GPD1L;YWHAH;SCN2B;FGF12;CAMK2D;PTPN3;FGF14;SCN1B;ATP2B4;SGK3;FGF13;COMMD1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.502365427938008,-1.3313242811632964,0.15555555555555556,1.0,1.0,7/13,19.11%,ERN1;PDGFC;IL1R1;PTPRJ;PDGFA;PDGFD;VEGFA
prerank,cardiolipin binding (GO:1901612),0.6294968942994477,1.325775494262082,0.16366366366366367,0.8203059434705605,1.0,2/10,2.84%,GSDMD;PLEKHN1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.47509836245665327,-1.3253309639372621,0.1388888888888889,0.9886883365452798,1.0,9/14,41.53%,CYB5R4;NOX1;CYBA;MICAL1;NCF2;AIFM1;CYBB;KMO;NOX4
prerank,gamma-tubulin binding (GO:0043015),0.5463034782182937,1.3239689695366588,0.12516823687752354,0.8174940049499237,1.0,10/21,17.17%,B9D2;DDX3X;ARHGEF7;NDRG1;BRSK1;DIXDC1;BLOC1S2;GIT1;OFD1;TUBGCP2
prerank,nucleotidase activity (GO:0008252),-0.4576435760637133,-1.3232448049949443,0.13028169014084506,0.9571048624365238,1.0,4/15,9.08%,NT5C2;BPNT2;NT5E;NT5M
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.37291061594579344,-1.3228756662466332,0.10526315789473684,0.920557006332123,1.0,15/31,27.28%,SLC12A7;KCNK5;ABCC9;TMEM175;TMEM38A;SLC12A4;TMEM38B;SLC12A9;KCNA2;SLC12A2;KCNK9;SLC12A8;KCNK1;HCN1;SLC12A6
prerank,phospholipase A2 activity (GO:0004623),0.5234808259338465,1.3148345253788922,0.12855377008652658,0.8503055318048715,1.0,2/26,5.71%,PLA2G5;PRDX6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4572313816024651,1.3146849585138627,0.07675675675675675,0.8395797266855602,1.0,12/75,12.14%,KCNAB2;PRXL2B;ADH5;RDH10;BDH1;RDH11;HADHB;HSD17B4;RDH5;MDH2;AKR1B10;EHHADH
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6176909810267133,1.3140760243063763,0.16137931034482758,0.8319938257564765,1.0,5/11,19.43%,NTHL1;APLF;HMCES;ALKBH1;RPS3
prerank,FAD binding (GO:0071949),0.5293691119017235,1.3137616151731388,0.13391739674593242,0.8224895608104339,1.0,2/24,1.50%,CYB5R2;NQO2
prerank,E-box binding (GO:0070888),0.4925266989219682,1.3114137264939314,0.1332533013205282,0.8226982641070689,1.0,9/34,16.26%,CIART;SNAI1;TCF4;ZEB1;PER1;PRMT5;TWIST1;TCF3;CLOCK
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6097664531516647,1.3111507883374085,0.15022761760242792,0.8135048800429966,1.0,3/12,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,mRNA 3'-UTR binding (GO:0003730),0.44640762550303215,1.3054211267038318,0.09753483386923902,0.8297582103332863,1.0,20/79,14.23%,ILF3;CPEB1;KHSRP;PCBP4;ZFP36L1;IGF2BP2;CELF2;EXOSC8;CELF1;RNF40;PABPC4;RBMS3;DHX36;PABPC1;RBMS1;NUDT21;RBMS2;HNRNPA0;CSDC2;HNRNPA2B1
prerank,carbohydrate kinase activity (GO:0019200),0.6091770247898247,1.2979272648681086,0.1689497716894977,0.8549021358637375,1.0,2/11,2.71%,XYLB;GALK1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5512990244727944,1.2973269790043334,0.14419225634178906,0.8472620441314506,1.0,7/19,16.38%,SELENOS;SYVN1;CHMP3;VCP;SART3;PARK7;DERL1
prerank,retinoic acid binding (GO:0001972),0.5995263440937267,1.296256959484495,0.1452991452991453,0.8420166605303764,1.0,2/12,12.85%,NR2F2;CYP26B1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5215279118773897,1.293303859196354,0.15424164524421594,0.8461794112241016,1.0,15/23,26.26%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1;HNRNPU;PTBP1;U2AF2;KHDRBS1;PNPT1;HNRNPH1;HNRNPC
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4997806063748811,-1.289051772264393,0.18012422360248448,1.0,1.0,5/11,22.53%,EGFR;TAOK2;MAP3K13;MAP3K4;MAP3K5
prerank,histone methyltransferase activity (GO:0042054),0.4946944770491534,1.2884651285252309,0.13277511961722488,0.8588125161709829,1.0,15/32,19.80%,PRMT6;FBL;SETD7;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;PRMT2;KMT5B;CARM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5345356937273298,1.283002105742258,0.16469038208168643,0.8745480040904419,1.0,6/20,14.26%,MOGAT3;AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.47267406220544106,-1.2774541904112886,0.15867158671586715,1.0,1.0,8/13,22.71%,GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5064989622332137,1.274829324381224,0.17103620474406991,0.9034148754478507,1.0,4/26,9.21%,B3GALNT1;CHPF;CHSY3;EXTL2
prerank,poly(U) RNA binding (GO:0008266),0.522590353665799,1.2746281838988114,0.18050065876152832,0.8941061983630046,1.0,8/20,16.78%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1
prerank,snRNA binding (GO:0017069),0.47179596545291874,1.2732554677637236,0.15182648401826485,0.8904236108219389,1.0,15/42,21.19%,HEXIM1;LSM7;COIL;TOE1;PRPF8;CDK9;SNRPB2;SART3;RBM41;CCNT1;RBM22;HNRNPU;GEMIN5;CCNT2;RBM7
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5056226574489452,1.2732411965857109,0.14251781472684086,0.8805924235105703,1.0,9/29,18.99%,CDKN2D;HEXIM1;PKIB;CIT;YWHAG;PKIG;SPRY2;PRKAR1A;PRKAG2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5282057797249333,1.2731979732593586,0.15984147952443858,0.8710904642734191,1.0,9/20,19.20%,OTULINL;USP7;USP47;UFSP2;SENP5;USP9X;EIF3F;USP50;YOD1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5080504840360474,-1.2702135022528893,0.2006269592476489,1.0,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,intracellular chloride channel activity (GO:0061778),-0.43596380676318375,-1.2652451328868815,0.19784172661870503,0.9933095850013437,1.0,10/16,36.92%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.43596380676318375,-1.2652451328868815,0.19784172661870503,0.9933095850013437,1.0,10/16,36.92%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,voltage-gated potassium channel activity (GO:0005249),0.43072130924274354,1.2625580627846593,0.13675213675213677,0.9126409275838095,1.0,13/80,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;KCNMA1;KCNC2;KCNJ10;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3481174019432113,-1.2624115198758736,0.13450292397660818,0.9725895468961395,1.0,20/33,30.23%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RRN3;RPRD1B;SCAF8;PAF1;SMYD2;SPTY2D1;CCAR2;ERBB2;SUPT4H1;CTR9;ELP4;MAF1;DHX9;RPRD1A
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5396507702081903,1.2616271521566353,0.18417462482946795,0.9070049183472181,1.0,3/17,5.66%,THEM4;ACOT9;ACOT11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.44868354985752246,1.2552554086542427,0.1455981941309255,0.927371697470224,1.0,12/54,13.47%,HDAC3;GLS2;SIRT2;SIRT7;MIER2;NGLY1;HDAC5;ASRGL1;HDAC4;NTAN1;HDAC1;NIT1
prerank,endopeptidase activity (GO:0004175),0.4071691664288303,1.2527297092894667,0.034102306920762285,0.9296908356219026,1.0,53/257,17.62%,ADAMTSL2;MMP12;MMP17;SFRP1;MMP11;ADAMTS7;RHBDL3;USP14;NRDC;USP7;USP30;UCHL1;CASP7;ADAMTS10;PCSK5;USP1;USP38;ADAMTS20;PCSK2;USP24;USP47;THOP1;PSMB10;USP42;HTRA3;ADAMTS5;ADAMTS6;USP10;PLAT;MBTPS1;CASP9;ADAM33;USP2;MALT1;AFG3L2;USP11;USP15;PRSS12;USP40;USP9X;ADAMTS3;CTSZ;F3;RHBDF1;CASP2;USP34;USP35;CTSH;USP48;ADAMTS1;PARL;USP33;OMA1
prerank,hexosaminidase activity (GO:0015929),-0.46744910981323473,-1.2522027212426088,0.20666666666666667,0.9820388884678192,1.0,5/12,26.04%,OGA;CEMIP2;HEXD;HYAL1;NAGA
prerank,NF-kappaB binding (GO:0051059),0.5113765690551856,1.2491097105228166,0.18193224592220827,0.9371883589164882,1.0,8/24,17.71%,HDAC3;COMMD6;CDK5RAP3;NPM1;HDAC1;FAF1;MTDH;ANXA4
prerank,MAP-kinase scaffold activity (GO:0005078),0.5859879742483719,1.248488781311418,0.21176470588235294,0.9306438245530865,1.0,6/11,19.09%,MAPK8IP1;IQGAP1;MAPK8IP3;AKAP13;MAP2K2;KSR1
prerank,retinoid binding (GO:0005501),0.5026043886546407,1.2476605465409571,0.20454545454545456,0.9252740528893878,1.0,4/22,12.85%,NR2F2;ALDH1A2;RBP1;CYP26B1
prerank,G protein-coupled receptor activity (GO:0004930),0.40650803763623067,1.247594347135751,0.04929577464788732,0.9162304363443102,1.0,29/239,14.70%,FSHR;S1PR2;MRGPRF;LTB4R2;MRGPRE;VIPR2;OPRK1;GPR22;GPR63;CXCR4;HCRTR2;ADGRV1;GPR37;BDKRB2;GPR149;GPR4;TPRA1;GPR45;ELOVL4;LGR4;PTH1R;HCRTR1;ADGRG1;LANCL1;GPR161;GABBR1;LPAR1;LPAR6;PDGFRL
prerank,hexose transmembrane transporter activity (GO:0015149),0.5732215458437784,1.247048366629695,0.21075581395348839,0.9094739744296688,1.0,3/12,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,outward rectifier potassium channel activity (GO:0015271),0.5773854842175082,1.245020102073932,0.2220609579100145,0.9092651535706654,1.0,4/11,18.02%,KCNK2;KCNT2;KCND3;PKD2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4443717627302296,-1.243586852220863,0.21428571428571427,0.9880216453497513,1.0,9/14,27.22%,CASP8AP2;BCL2L13;NOD1;EBAG9;MAL;APAF1;BAD;ATP2A3;RPS27L
prerank,chloride channel inhibitor activity (GO:0019869),0.6019590799427256,1.2420405457394357,0.2394578313253012,0.9146588246357648,1.0,7/10,26.39%,WNK2;VTI1B;STX8;VAMP8;WNK3;STX7;STX1A
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5697680243596435,1.2388720594281053,0.2132768361581921,0.9207748265291906,1.0,7/12,22.48%,POU2F1;TBP;HDAC1;TBPL1;H3-3A;TAF1;GTF2B
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5767889784801654,1.2380101438931015,0.22633136094674555,0.9158997556604026,1.0,3/10,12.26%,SIRPA;JUP;CD47
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.515420522182222,1.2328353710554996,0.2147477360931436,0.9300094467455748,1.0,9/20,21.40%,CASK;AK4;AK3;AK6;MAGI3;DLG2;CMPK1;MPP1;AK1
prerank,alkali metal ion binding (GO:0031420),0.555496289865169,1.230976627398248,0.22140762463343108,0.9301113019063908,1.0,4/13,9.36%,ACAT1;ATP1A2;DRG1;HDAC4
prerank,acylglycerol lipase activity (GO:0047372),-0.4910735144118522,-1.2308742438285236,0.25084745762711863,1.0,1.0,3/11,7.16%,MGLL;ABHD6;ABHD2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4379344638504211,1.2302812995305377,0.1864406779661017,0.9246907376311532,1.0,12/49,15.67%,DUSP28;DUSP18;SMPDL3B;GDPD3;ATP1A2;PRUNE1;PPP1CC;HDHD2;PTPN22;EPHX2;PPP5C;SACM1L
prerank,kinase inhibitor activity (GO:0019210),0.47353097440379804,1.2269467869527746,0.20435308343409916,0.9307600806844213,1.0,7/33,8.79%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;WARS1;MAPK8IP1;SH3BP5L
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4287446388767676,1.2242573198104465,0.18458197611292074,0.9344078050534306,1.0,15/60,13.11%,MST1R;EPHA7;EPHB2;FGFRL1;FGFR2;FGFR1;DDR1;NRP1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;IGF2R;ROR2
prerank,calcium ion binding (GO:0005509),0.3953669548761703,1.2241853384425165,0.042042042042042045,0.9261940262837918,1.0,75/323,21.79%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;RASGRP2;SPARC;ADGRV1;RCN3;SPOCK1;CRACR2A;CDH11;PITPNM3;ENPP2;MCTP2;BNIP2;IQGAP1;ENPP1;FBN1;SYT1;SPOCK2;PAM;LRP1;CDH18;SLIT1;SLIT3;EFHD1;ANXA2;MAN1C1;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SCUBE1;CALM1;TPM4;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;GSN;SYT11;SYT12;CDH10;SDF4;CALM2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4817960134485879,1.2227278427256434,0.20797011207970112,0.924917261550544,1.0,6/25,12.91%,CYP27A1;POR;MSMO1;CYP26B1;FMO4;FMO2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5528676971370349,1.2218381231948705,0.24390243902439024,0.9206041718953518,1.0,5/13,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,pentosyltransferase activity (GO:0016763),0.4597436620165415,1.2214809775066666,0.20260663507109006,0.9140146799997686,1.0,13/36,18.69%,SIRT2;PARP1;PARP2;UPP2;PARP14;PARP16;LACC1;SIRT5;ZC3HAV1;TNKS;TIPARP;QTRT2;PARP11
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.49037839572966,1.2211897730051227,0.22010178117048346,0.9074833118368689,1.0,10/25,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.46613644758776396,-1.2196034603999615,0.20065789473684212,1.0,1.0,7/12,25.44%,DAB2IP;VEGFC;CADM4;VEGFA;VEGFB;PGF;ITGB3
prerank,kinesin binding (GO:0019894),0.48199217547794887,1.2171990802435468,0.2098159509202454,0.9168819829579447,1.0,7/27,12.38%,SPTBN5;ARHGEF10;MAPK8IP1;NEFH;TOR1B;PLEKHM2;MAPK8IP3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3733213018914909,-1.2169669754239603,0.18779342723004694,1.0,1.0,8/23,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,ankyrin binding (GO:0030506),-0.39760223969638264,-1.2134563077723624,0.21008403361344538,0.9968191338382818,1.0,6/19,17.94%,CACNA1D;CDH1;PLEC;PTPRC;SPTB;KCTD6
prerank,copper ion binding (GO:0005507),0.4418441403647303,1.212413844694047,0.20765661252900233,0.9293546969221946,1.0,12/42,21.53%,GPC1;CUTA;COX17;PARK7;SOD3;PAM;LACC1;HEPH;MOXD1;S100A13;COMMD1;ATOX1
prerank,protein kinase C binding (GO:0005080),0.4457160050629272,1.211220697450705,0.21264367816091953,0.9266281935650116,1.0,16/43,23.21%,DACT2;PICK1;NELL1;TIRAP;ABL1;SQSTM1;HDAC5;YWHAG;RACK1;PRKD2;CCDC88A;ITGAV;TOP2B;PARD6G;PKN1;HINT1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5697043051198398,1.2101759651111954,0.2543604651162791,0.9233846401959278,1.0,3/11,19.36%,SLC22A4;SLC25A20;SLC25A47
prerank,potassium channel regulator activity (GO:0015459),0.4410979353115881,1.2096756374564317,0.19932810750279956,0.9175996221445453,1.0,3/49,4.12%,AMIGO1;KCNAB2;SLC5A3
prerank,methyltransferase activity (GO:0008168),0.43713041179115764,1.2088468293203183,0.21395348837209302,0.9135336385358828,1.0,12/46,13.05%,COMTD1;LCMT1;MGMT;BUD23;NNMT;PRMT5;NTMT1;SUV39H1;CARNMT1;COMT;PRMT1;EHMT1
prerank,retinoic acid receptor binding (GO:0042974),-0.40128326265798514,-1.2079918548234527,0.21686746987951808,0.9927808503778929,1.0,9/17,23.38%,CNOT1;NCOA6;MED1;RARG;ASXL1;MED25;NRIP1;PPARG;NR4A2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.43627452959756435,1.2074325641501733,0.2026578073089701,0.912219452481591,1.0,6/53,6.76%,CYB5R2;GFER;NQO2;AIFM2;SDHA;POR
prerank,ionotropic glutamate receptor activity (GO:0004970),0.52275355272958,1.2039133266797835,0.2368064952638701,0.920080889817423,1.0,10/17,24.56%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,O-acyltransferase activity (GO:0008374),0.4688427686127342,1.2020583301312269,0.2438423645320197,0.9209115249357698,1.0,5/30,9.52%,MOGAT3;PRDX6;GPAT4;SOAT1;GPAM
prerank,ribonuclease activity (GO:0004540),0.4237790286386892,1.1959244011171524,0.23986856516976998,0.940262537069617,1.0,15/56,17.10%,EXOSC1;EXOSC3;EXOSC7;RNASE1;EXOSC2;RNASE7;LACTB2;EXOSC8;RCL1;CPSF3;AGO3;SND1;DIS3L2;CNOT6;ZC3H12C
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.47602658952559074,-1.1955054757889783,0.2326283987915408,1.0,1.0,8/10,32.97%,PML;DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.351435798284165,-1.1948080073968719,0.21195652173913043,0.9924724218475468,1.0,14/29,38.20%,SLC26A7;SLC25A13;SLC26A2;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6;SLC26A8
prerank,chloride channel regulator activity (GO:0017081),0.5399209809043954,1.1919754553131385,0.27285513361462727,0.9505567766507227,1.0,9/14,26.39%,WNK2;VTI1B;STX8;VAMP8;SGK3;WNK3;SGK1;STX7;STX1A
prerank,metalloexopeptidase activity (GO:0008235),0.43087921024713016,1.1889899754899733,0.22717149220489977,0.955954981300899,1.0,16/51,20.33%,MMP17;XPNPEP3;CPXM1;ANPEP;METAP1;LAP3;AGBL3;PEPD;METAP1D;CPXM2;METAP2;AGBL4;DPEP1;AGTPBP1;MMP14;MMP16
prerank,protein phosphatase activator activity (GO:0072542),0.5420602859668666,1.1865876990810753,0.2587904360056259,0.9588946913880799,1.0,8/13,24.08%,CALM3;PPP2R5E;IGFBP3;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,5'-nucleotidase activity (GO:0008253),-0.4241863128050499,-1.1848451112628193,0.22508038585209003,1.0,1.0,3/13,9.08%,NT5C2;NT5E;NT5M
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4480722824792205,-1.184637354974218,0.24161073825503357,0.9832754389815844,1.0,6/12,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;LTBP4;BMPR1B
prerank,signal sequence binding (GO:0005048),0.44698697227223666,1.1827413834432563,0.26971428571428574,0.967697760512176,1.0,15/35,20.69%,KDELR3;KPNA3;SEC61A2;BRAP;TOMM20;KPNB1;PEX5;NUP214;TNPO1;CEMIP;NUP153;KPNA1;TIMM22;CABP1;PEX5L
prerank,fibroblast growth factor binding (GO:0017134),0.4887024052123344,1.1823347220155156,0.23291139240506328,0.961930599473197,1.0,5/21,9.70%,FGFRL1;FGFR2;FGFR1;GPC1;KL
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.43839708656565324,1.1799458081252359,0.24133811230585425,0.9645692787099027,1.0,8/38,16.65%,SERPING1;SPOCK1;APP;TFPI;SERPINA2;SERPINE1;SERPIND1;ANXA2
prerank,aminopeptidase activity (GO:0004177),0.4722456046944276,1.1788729759472796,0.25798212005108556,0.9620940156591286,1.0,8/26,15.68%,MMP17;XPNPEP3;ANPEP;METAP1;LAP3;METAP1D;METAP2;CTSH
prerank,phosphatase activator activity (GO:0019211),0.5296407629511345,1.178569168398456,0.27566807313642755,0.9560606837796154,1.0,8/14,24.08%,CALM3;FRS2;PPP2R5E;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5086755102074787,1.178396548243905,0.2684563758389262,0.9496113040066729,1.0,1/16,0.55%,HGD
prerank,phospholipase C activity (GO:0004629),-0.3528122200201396,-1.1774302049007044,0.2079207920792079,0.9869728151515874,1.0,8/25,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,double-stranded RNA binding (GO:0003725),0.4112203301550695,1.1765925462016709,0.21943231441048036,0.9500066702049696,1.0,20/70,17.09%,ILF3;APTX;TARBP2;DGCR8;PRKRIP1;DDX3X;DHX15;DHX30;DHX58;DHX33;DHX36;RC3H2;AGO3;TLR3;SIDT1;TUBA1B;HSPD1;FMR1;OAS2;MTDH
prerank,phospholipase inhibitor activity (GO:0004859),0.5663049385916371,1.1764109990545946,0.2857142857142857,0.9437739582338909,1.0,3/10,17.71%,ANXA1;ANXA2;ANXA4
prerank,protein kinase C activity (GO:0004697),-0.40893945018259104,-1.175561619770828,0.24363636363636362,0.9712501949622384,1.0,4/14,4.51%,PRKCH;PRKCE;PRKCD;PRKD1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.45568732856907723,1.1753948193187989,0.2609223300970874,0.9409781756792944,1.0,8/33,15.43%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;XRN1;DIS3L2;CNOT6
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3190766378580349,-1.1748978995577948,0.1907514450867052,0.9525056327644299,1.0,11/38,17.58%,PARD3;DAB2IP;DENND1A;ATG2B;ZFYVE26;TECPR1;ZFYVE1;HIP1;BBS5;KIF16B;ZFYVE19
prerank,acetyltransferase activity (GO:0016407),-0.3365089189739611,-1.1744030240148415,0.20218579234972678,0.9337941600193407,1.0,11/31,20.27%,SMARCE1;ELP3;NAA15;KAT2B;SAT1;EP300;PAFAH1B2;NAT10;KAT6B;KAT8;NAA80
prerank,four-way junction DNA binding (GO:0000400),0.4966746705529692,1.1743902987947203,0.3046448087431694,0.9382642056641722,1.0,5/17,11.61%,XRCC2;HMGB3;ABL1;FANCM;YY1
prerank,RNA cap binding (GO:0000339),-0.4010041410478106,-1.1737325814750386,0.22661870503597123,0.9162747419791472,1.0,7/16,11.40%,NCBP3;AGO2;DCPS;EIF4E;NCBP1;LSM1;SNUPN
prerank,cytokine receptor activity (GO:0004896),0.40420800114476185,1.173469276991279,0.2297008547008547,0.9354199806009975,1.0,14/83,16.36%,IL10RA;IFNAR1;IL10RB;CCR9;ACKR2;IL31RA;IFNGR2;PRLR;GFRA2;LEPR;IFNGR1;F3;IL15RA;IL1RAP
prerank,chemokine binding (GO:0019956),0.4467690040582269,1.173382096413302,0.2484700122399021,0.9290876886723652,1.0,7/30,22.00%,CCR9;ACKR2;CXCR4;ITGAV;ITGB1;FGF2;HMGB1
prerank,voltage-gated calcium channel activity (GO:0005245),0.4411882722473022,1.1717662029722755,0.2709529276693456,0.9290109129146845,1.0,6/37,10.31%,CACNA2D2;CACNG3;CACNB4;CACNA2D3;CATSPER3;CACNB1
prerank,pseudouridine synthase activity (GO:0009982),0.5277984252063554,1.1713586079927412,0.2855093256814921,0.9240620623990877,1.0,3/13,9.92%,TRUB2;PUS10;PUS7
prerank,tubulin binding (GO:0015631),0.38221952774630374,1.1713046649073444,0.119,0.9177457636394275,1.0,82/295,20.18%,PSRC1;CFAP157;FSD1;B9D2;ARL4C;CCDC61;CCDC170;REEP4;STMN4;DNM1;WHAMM;MAPRE3;TTLL4;TAOK1;KIF3A;DDX3X;DIP2B;MDM1;RAE1;NEFH;ALMS1;CDK5;TBCA;MTCL1;ARHGEF7;KIF3C;MACO1;TPPP3;GAS2L1;VBP1;RMDN2;PRUNE1;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;BRSK1;TPGS1;DIXDC1;KIF5C;DAG1;BLOC1S2;GIT1;HTT;RABGAP1;MAPT;UNC5C;MAP1LC3B;EML2;DNM1L;OFD1;VAPB;TBCD;TTLL11;AGBL4;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;PACRG;CCDC88A;EML3;ARL8B;PDCD5;KIF20B;KRIT1;MAP6D1;AGTPBP1;RPS3;DNAL1;DLEC1;PAFAH1B1;INO80;KIF6;DCX
prerank,thyroid hormone receptor binding (GO:0046966),0.45543964507747725,1.1701147204207205,0.27195121951219514,0.9161395150674592,1.0,14/28,22.51%,MED24;MED12;MED13;TACC1;GAS2L1;MED4;BRD8;THRAP3;NSD1;PRMT2;NCOA3;TRIP12;GTF2B;MED17
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.5291699558427839,1.1643604447421347,0.2926490984743412,0.9330440534660153,1.0,8/13,24.61%,PIP4K2B;PIK3CB;PIP4K2A;PIP4K2C;PIK3C2B;PIP5K1A;PIKFYVE;PIK3C2A
prerank,acetylation-dependent protein binding (GO:0140033),0.4785260133503122,1.1642763612418072,0.28366013071895424,0.9205768071709776,1.0,9/20,22.19%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,lysine-acetylated histone binding (GO:0070577),0.4785260133503122,1.1642763612418072,0.28366013071895424,0.9205768071709776,1.0,9/20,22.19%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4750317734303643,1.1630647046925402,0.29514321295143214,0.9191414758540084,1.0,10/24,22.39%,CAMK2B;CAMK1G;CAMK2D;CAMK2G;DAPK1;CAMK1D;PHKA2;PTK2B;MAPKAPK2;EEF2K
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.31524115805357644,-1.159050615728997,0.17647058823529413,0.9484231704712229,1.0,11/34,16.08%,GBF1;PARD3;MYO10;FERMT2;ARAP2;PLEKHB2;ZFYVE1;DAPP1;IQGAP2;ARAP3;KIF16B
prerank,calcium channel activity (GO:0005262),0.39671098466663707,1.1586725963190978,0.22860125260960334,0.9309198498456138,1.0,11/84,10.31%,CACNA2D2;PKD2L2;SLC24A5;ORAI2;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;SLC24A4;CACNB1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3779071881865578,1.1561547083333126,0.16148445336008024,0.9346176133594408,1.0,67/232,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;PIAS3;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;PIAS1;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3756989442841496,-1.1533999385422191,0.26956521739130435,0.949696105626971,1.0,7/18,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;ACVR2B;LTBP4;BMPR1B
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.43492687036076094,-1.1524963284865095,0.2896551724137931,0.9340508361296189,1.0,9/13,28.90%,TRMT1L;THUMPD3;THUMPD2;TARBP1;FTSJ1;TRMT10B;METTL1;TRMT10A;TRMT5
prerank,ligand-gated anion channel activity (GO:0099095),-0.38483772823847606,-1.1521596633905309,0.2551440329218107,0.9171952217458955,1.0,9/17,22.71%,GABRB1;GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,mRNA 5'-UTR binding (GO:0048027),0.467211501622596,1.1508526261258842,0.28428927680798005,0.9501486259473462,1.0,5/24,10.47%,GNL3;DDX3X;IGF2BP2;DHX36;MYH10
prerank,steroid hydroxylase activity (GO:0008395),0.49808000556609994,1.1483165990751145,0.3079019073569482,0.954327217251341,1.0,2/16,6.55%,CYP27A1;CYP7B1
prerank,NADPH binding (GO:0070402),-0.4307861222088452,-1.1479031311886834,0.26229508196721313,0.9131518092953466,1.0,11/13,41.91%,LBR;DECR1;DUS2;MTRR;CBR4;DHFR;KCNAB1;NDOR1;CRYZ;CBR3;GRHPR
prerank,chloride transmembrane transporter activity (GO:0015108),-0.39696919366046773,-1.1441871383752291,0.26296296296296295,0.9080675383113134,1.0,3/16,6.46%,SLC26A7;SLC26A2;CLCN6
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.31419585231916675,-1.1397016456483273,0.21764705882352942,0.905697991956803,1.0,11/33,13.99%,PCF11;WAC;ERCC5;AR;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2
prerank,calcium activated cation channel activity (GO:0005227),0.49830207619119493,1.1396469252592558,0.3293010752688172,0.9829009461818972,1.0,3/17,6.83%,TMEM63A;TMEM63C;KCNMA1
prerank,adenylate cyclase binding (GO:0008179),0.5421141605087092,1.1396125316780639,0.3373860182370821,0.9766603110041973,1.0,5/10,21.79%,CALM3;AKAP12;ADCY5;CALM1;CALM2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4002242660311954,1.1389526940022148,0.2831196581196581,0.9729504539650601,1.0,8/70,9.03%,B3GALNT1;B3GLCT;CHPF;OGT;MGAT4B;POMGNT1;CHSY3;MGAT4C
prerank,actin binding (GO:0003779),0.37905142330569125,1.1388433817227452,0.22267206477732793,0.9671746343505511,1.0,32/170,13.92%,FHL3;PDLIM2;TNNI3;SPTBN5;LCP1;PDLIM7;ABITRAM;MYO19;VPS16;CGN;BCL7B;ARPC1A;MRTFA;ABL1;DMTN;DBN1;KCNMA1;CXCR4;GC;PHACTR3;SSH1;DBNL;PLEKHH2;MYH10;CAPZA1;TPM1;MOBP;FLNB;DAG1;ADD2;TLN2;MAPT
prerank,ubiquitin protein ligase activity (GO:0061630),0.37146438023097367,1.1386744478182707,0.19759277833500502,0.9616048813994469,1.0,65/228,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,glucose transmembrane transporter activity (GO:0005355),0.4880309358421001,1.1381576101442739,0.3243606998654105,0.9575907637798755,1.0,3/17,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5044915283284015,1.1377382177948245,0.3352112676056338,0.9532897416264495,1.0,5/15,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,transforming growth factor beta binding (GO:0050431),-0.3500886107903775,-1.1349971351256294,0.2986425339366516,0.9033920610750138,1.0,10/23,21.27%,TWSG1;ACVR1;THBS1;ENG;TGFBR2;LTBP4;CD109;NRROS;TGFB3;LRRC32
prerank,calcium-dependent phospholipid binding (GO:0005544),0.410849637701351,1.1317024419760997,0.287317620650954,0.9713567544553467,1.0,17/49,23.25%,SYT3;SYT10;ANXA1;RPH3A;CPNE7;MCTP2;SYT1;CPNE8;ANXA2;ANXA4;MCTP1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4210402379446056,1.1296504470614985,0.305978898007034,0.9732428412049089,1.0,10/40,12.90%,COMTD1;LCMT1;FBL;DPH5;NNMT;SUV39H1;CARNMT1;COMT;METTL2A;METTL2B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.491225662810966,1.1293013945573986,0.3190883190883191,0.9627299210744752,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.491225662810966,1.1293013945573986,0.3190883190883191,0.9627299210744752,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,acid-thiol ligase activity (GO:0016878),-0.42334297526532355,-1.1287882852143785,0.3250883392226148,0.9090971729379258,1.0,4/13,26.04%,AASDH;AACS;ACSS1;ACSS2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.43450602450583903,1.1278393976716958,0.31425091352009743,0.9625609604604802,1.0,5/34,5.02%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1
prerank,protein kinase inhibitor activity (GO:0004860),0.4198378508656335,1.1272726019314976,0.3081395348837209,0.9586609746401642,1.0,9/42,12.69%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;MAPK8IP1;CIT;SH3BP5L;NPM1;RACK1
prerank,potassium channel activity (GO:0005267),0.3819680975524778,1.1257635884715806,0.28012684989429176,0.958864805063238,1.0,13/89,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;GRIK5;KCNMA1;KCNC2;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,GTPase binding (GO:0051020),0.36864662069998877,1.1248437103763116,0.22548028311425683,0.9568612094728667,1.0,64/194,21.18%,UNC13D;CDC42EP5;LCP1;CDC42EP4;MTSS2;TSC2;RAB11FIP4;HSP90AA1;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;ATG14;TRIP11;GNB2;MYCBP2;RAP1GAP;CYFIP1;EPRS1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;RADIL;RNF41;DNM1L;SPTBN1;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;AMBRA1;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;YBX1;RUSC2;RAB11FIP3;MAPKAP1
prerank,GDP binding (GO:0019003),-0.2701397613625794,-1.1184650632870041,0.2125,0.9283100401192808,1.0,17/63,12.41%,RAB2A;KRAS;RAB18;RAB14;NRAS;RRAGC;RHEB;RAB5C;RALB;RAB27A;ARL3;RAB22A;RAB9A;RIT1;RASL12;GNAI3;MIEF1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4368849365746643,-1.117218163976508,0.33116883116883117,0.9168807588378507,1.0,2/11,0.69%,MBD2;LEF1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.39909974174698976,1.1160338104692253,0.3089700996677741,0.9850506345511616,1.0,8/55,8.64%,PKD2L2;SLC24A5;ATP2C1;GRIN1;ATP2A2;ITPR1;ATP2B1;SLC24A4
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.23152887437338313,-1.1123605078815892,0.10526315789473684,0.916895980974552,1.0,26/134,11.94%,ABCG2;SLCO3A1;ABCC4;SLC6A6;GJA1;SLC25A17;SLC26A7;SLC25A13;ABCC1;SLC3A2;SLC26A2;SLC7A1;SLC35B3;SLC6A9;SLCO1C1;SFXN2;SLCO2A1;SLC16A1;SLC25A32;SLC52A1;SLC36A4;CTNS;SLC39A8;SLC35D1;SLC22A6;SLC16A11
prerank,GABA-A receptor activity (GO:0004890),-0.3681945122009044,-1.1114842081903584,0.2869198312236287,0.9044669372230989,1.0,6/18,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,monocarboxylic acid binding (GO:0033293),0.47400156961120316,1.1112387471865581,0.34822601839684625,0.9982775108222333,1.0,3/18,13.84%,NR2F2;CYP26B1;PSAP
prerank,damaged DNA binding (GO:0003684),0.4065588179614502,1.110749945814106,0.33797909407665505,0.9941984806039462,1.0,8/44,10.65%,APTX;NTHL1;MPG;SDE2;DDB1;FANCG;CUL4B;DCLRE1A
prerank,metalloaminopeptidase activity (GO:0070006),0.4770667598280472,1.1088142498302427,0.33879781420765026,0.9955143673760654,1.0,3/16,5.44%,MMP17;XPNPEP3;ANPEP
prerank,small GTPase binding (GO:0031267),0.3662434536281322,1.107922962528364,0.2813765182186235,0.9929937199427271,1.0,55/169,21.18%,UNC13D;CDC42EP5;CDC42EP4;MTSS2;TSC2;RAB11FIP4;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;TRIP11;MYCBP2;RAP1GAP;CYFIP1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;RNF41;DNM1L;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;RUSC2;RAB11FIP3;MAPKAP1
prerank,histone deacetylase binding (GO:0042826),0.3816920202562747,1.1074556272332379,0.3147953830010493,0.9888260646675116,1.0,16/88,12.36%,CAMTA2;HDAC3;SIRT2;HSP90AA1;USF1;MIER2;NIPBL;RBBP4;AKAP8L;HDAC5;DHX36;HDAC4;NUDT21;NACC2;MTA2;HDAC1
prerank,nuclear receptor coactivator activity (GO:0030374),0.39721044722997734,1.1074035045727302,0.33444816053511706,0.9833051077433788,1.0,21/52,22.79%,MED24;MED12;MED14;MED13;TACC1;MED4;SLC30A9;SRA1;CALCOCO1;BRD8;CNOT9;ZMIZ1;CNOT6;THRAP3;USP22;NCOA3;CARM1;FGF2;PKN1;MED17;NCOA1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.43780520071981766,-1.1061811950844915,0.3191489361702128,0.9071859807956817,1.0,5/11,20.27%,NAA15;NAA40;NAA25;NAA60;NAA80
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5312245623120411,1.1053863734982994,0.355359765051395,0.9853581339515801,1.0,7/10,26.14%,PKIB;PKIG;PRKAR1A;PRKAG2;PKIA;PRKAR1B;PRKAR2A
prerank,ubiquitin binding (GO:0043130),0.3874437186678635,1.1043730224355135,0.3208154506437768,0.9834934150626435,1.0,15/73,9.09%,OTULINL;MVB12A;SIRT2;UBXN2A;USPL1;UCHL1;RAE1;TNFAIP3;FBXO7;UBXN7;SQSTM1;UCHL3;CXCR4;RNF168;AUP1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4177908953240563,1.104177845655296,0.34787735849056606,0.9786766240261323,1.0,8/35,13.94%,SMPDL3B;GPLD1;SMPD2;GDPD3;ENPP2;ENPP1;TDP2;SMPD4
prerank,glutathione transferase activity (GO:0004364),0.44283400648816734,1.0998732322835338,0.35192069392812886,0.9892677754258117,1.0,2/23,4.08%,ALOX5AP;GSTT1
prerank,3'-5' exonuclease activity (GO:0008408),0.40105621957643256,1.0976867555994938,0.34619750283768447,0.9920615926466675,1.0,6/45,5.02%,EXOSC3;TOE1;APLF;EXOSC7;EXOSC2;USB1
prerank,ligand-gated calcium channel activity (GO:0099604),0.4695895868817701,1.0951143691329053,0.36270753512132825,0.9962519161127847,1.0,3/19,8.22%,GRIN1;ITPR1;GRIN2A
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5198226604367735,1.091019419272393,0.3668639053254438,1.0,1.0,4/10,14.75%,HADHB;HSD17B4;EHHADH;ECHDC1
prerank,calcium channel regulator activity (GO:0005246),0.4154133554955766,1.0900374440007001,0.34889148191365227,1.0,1.0,14/37,25.77%,TNNI3;ITPR1;PACSIN3;STIMATE;SLC30A1;CACNG4;CALM1;SGK3;CALM2;FKBP1A;SGK1;NRXN2;STIM2;STIM1
prerank,DNA replication origin binding (GO:0003688),-0.3403749393173268,-1.0885347500350442,0.31100478468899523,0.9527056717498055,1.0,19/23,50.34%,KAT7;ORC4;ORC5;MCM6;MCM4;DDX11;DHX9;ORC1;MCMDC2;MCM8;CDC45;MCM3;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.44310327497354285,1.0869639230219836,0.36632390745501286,1.0,1.0,8/21,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.39792048673062796,1.086274051408748,0.35354691075514877,1.0,1.0,10/49,9.82%,UBQLN1;PSMD4;PRPF8;TNFAIP3;OTUD7A;SQSTM1;ZFAND6;RNF168;ABRAXAS2;VCP
prerank,fatty acid synthase activity (GO:0004312),0.5213049990975369,1.086151296223018,0.3695324283559578,1.0,1.0,3/10,19.11%,ELOVL1;ELOVL4;ELOVL6
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.40008467796894776,-1.086139387627499,0.35443037974683544,0.9457335193039685,1.0,5/12,8.02%,NCBP3;AGO2;DCPS;EIF4E;NCBP1
prerank,phosphatidylglycerol binding (GO:1901611),0.4879734078457967,1.086071109797161,0.39067055393586003,0.9977275822904887,1.0,2/13,2.84%,GSDMD;PLEKHN1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4602683185963087,1.0857372080522465,0.376984126984127,0.993722347310132,1.0,6/18,18.94%,PRDX5;XIAP;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,exopeptidase activity (GO:0008238),0.3952625643645609,1.0844878243557154,0.3592880978865406,0.9931490236172298,1.0,13/50,16.81%,XPNPEP3;DPP9;ANPEP;METAP1;LAP3;METAP1D;CNDP2;GGH;METAP2;DPP10;CTSZ;CTSH;DPEP1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.486386868934056,1.082580544318252,0.3803418803418803,0.994777710446107,1.0,4/14,15.38%,AASS;BLVRB;ALDH4A1;QDPR
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4076876965608339,1.0801757055068457,0.36780258519388953,0.9986279387415562,1.0,11/35,19.88%,DTWD1;TRDMT1;GATB;PUS10;AARS1;TARS2;NT5C3A;QTRT2;FTO;ALKBH1;MTFMT
prerank,ion channel activity (GO:0005216),0.37394913325528345,1.0794822110619007,0.3705263157894737,0.9961261818837112,1.0,9/80,8.77%,TMC5;NALCN;LRRC8A;TMEM63A;GRIN1;GRIK5;CALHM2;GRIN2A;TRPM3
prerank,transcription coregulator binding (GO:0001221),0.38546645975778265,1.0785629395636376,0.386986301369863,0.9945034268315192,1.0,11/50,13.05%,HDAC3;RORA;CDK9;PHF1;EZH2;CHD6;CIT;EHMT2;PER1;USP11;EHMT1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4123680517810559,1.0769303334486975,0.3763313609467456,0.9954329152827825,1.0,14/34,21.79%,INCENP;CALM3;TAOK1;DDX3X;ALS2;IQGAP1;PARP16;MAP2K2;CCNT1;SPRY2;CAB39L;CALM1;CCNT2;CALM2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.3833492921267408,-1.0762024671605372,0.344,0.9651793527316322,1.0,10/15,51.51%,P2RY14;P2RX7;P2RY12;P2RY1;GPR34;P2RX4;PTAFR;P2RX5;P2RX3;P2RX6
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4099456970520826,-1.0758204309407733,0.34057971014492755,0.9517424070971507,1.0,6/12,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.48862531097520845,1.0756209558480545,0.38944365192582026,0.995091670064709,1.0,3/12,5.86%,CDK13;CDK9;BRD4
prerank,carboxy-lyase activity (GO:0016831),0.4402986486739431,1.0746796552936178,0.3838120104438642,0.9934655639749413,1.0,3/23,2.69%,AZIN2;MLYCD;UROD
prerank,lipid phosphatase activity (GO:0042577),0.485241653145704,1.0731045823280116,0.3925104022191401,0.994184447953956,1.0,4/14,14.71%,PLPPR2;PLPP3;PLPPR5;EPHX2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4726999016287645,1.0713439812611696,0.42128279883381925,0.9955025674752276,1.0,2/13,10.98%,DNASE1L2;ENDOV
prerank,pyridoxal phosphate binding (GO:0030170),0.4504313517765504,1.0708414886019997,0.3759894459102902,0.9922597311059177,1.0,3/20,8.15%,PSAT1;ABAT;OAT
prerank,protein tyrosine kinase activity (GO:0004713),0.36065494418556865,1.0701509089083727,0.3559670781893004,0.9896831901166291,1.0,16/108,11.29%,AATK;MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;WEE1;EPHA8;TEC;EPHA10;MUSK;PDGFRA
prerank,deoxyribonuclease activity (GO:0004536),0.47917403810071046,1.0699547945410208,0.38764044943820225,0.98546257144586,1.0,3/14,6.72%,DNASE1L2;APLF;DFFB
prerank,nuclease activity (GO:0004518),0.38011948543283713,1.0664377522649753,0.4022346368715084,0.9930231723112041,1.0,12/52,15.16%,DNASE1L2;NTHL1;RNASE1;RNASE7;DFFB;N4BP2;AEN;ENPP1;SND1;ISG20L2;DIS3L2;MRE11
prerank,endopeptidase inhibitor activity (GO:0004866),0.3632540919374306,1.0653650699504222,0.38065194532071506,0.991915749856404,1.0,17/82,20.45%,BIN1;USP14;RENBP;SERPING1;CARD16;SPOCK1;UBE2Z;APP;TFPI;SERPINA2;SPOCK2;SERPINE1;SERPIND1;ANXA2;TIMP2;PROS1;SERPINF1
prerank,leak channel activity (GO:0022840),0.45400393752506574,1.065172034341019,0.4244031830238727,0.9876633442444283,1.0,2/18,5.33%,NALCN;KCNK2
prerank,phospholipase activator activity (GO:0016004),0.5085026664534182,1.0636661870593787,0.4072398190045249,0.9880781241205465,1.0,1/10,2.08%,PDPK1
prerank,lipase activator activity (GO:0060229),0.5048095082428001,1.0627942302961695,0.41515151515151516,0.9864146771800371,1.0,1/10,2.08%,PDPK1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.39432797873828107,-1.0620164781360146,0.3746031746031746,0.9846203764196227,1.0,7/12,27.22%,CASP8AP2;BCL2L13;NOD1;APAF1;BAD;ATP2A3;RPS27L
prerank,phosphatase inhibitor activity (GO:0019212),-0.341027722225245,-1.0617129542858312,0.35,0.9711092584043601,1.0,6/20,12.59%,PPME1;ENSA;URI1;STYX;LMTK2;ANP32E
prerank,disordered domain specific binding (GO:0097718),0.42436375919231073,1.061448988336055,0.3977272727272727,0.9861830633540817,1.0,11/23,21.79%,HSP90AA1;CALM3;DFFB;KCNA1;FKBP8;NUMA1;MDM2;CALM1;NCOA3;SMAD2;CALM2
prerank,transcription cis-regulatory region binding (GO:0000976),0.341745504436778,1.0607711554212047,0.318,0.9837269919994204,1.0,87/406,18.54%,MMP12;HSF2;FOXM1;ZBTB48;NFKB1;ZNF25;ZBTB46;ZNF568;CREBZF;MLXIP;NKX2-2;GLIS2;STAT6;XBP1;RORA;TFDP1;PSPC1;MXI1;TAF4;RFX5;SNAI1;MTERF3;TCF7L2;PRDX5;TFCP2;IRF1;TBP;ZNF35;CASZ1;ARNT;ZBTB7B;TEAD1;HDAC5;ZBTB5;DBP;NFX1;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;RBL2;HOXB8;ATF2;ZBTB20;SUV39H1;FOXN3;YY1;E2F3;PARK7;PEG3;SOX6;NPM1;HDAC1;CREB3;SETX;HNRNPL;TRPS1;SMAD6;SOX5;KMT2D;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;HOXC8;TIPARP;ZFP37;SOX13;OSR1;ZFP90;TCF7;NFXL1;GABPB1;GABPB2;TBL1XR1;ZNF177;CUX1;NONO
prerank,ribosome binding (GO:0043022),0.3879507970124555,1.0562130831827974,0.4284064665127021,0.9952053847874626,1.0,9/46,13.42%,SRP19;CPEB1;SEC61A2;NCLN;SHFL;YTHDF3;RACK1;SRP68;YTHDF1
prerank,CoA-ligase activity (GO:0016405),-0.38285827215899465,-1.0560229547384814,0.3859060402684564,0.9760702252416749,1.0,6/14,44.26%,AACS;ACSS1;ACSS2;ACSBG1;SLC27A2;ACSF3
prerank,5'-3' exonuclease activity (GO:0008409),0.4657495711421441,1.0528793395375757,0.4238505747126437,1.0,1.0,4/14,15.16%,DCLRE1A;CPSF3;XRN1;MRE11
prerank,protein phosphatase regulator activity (GO:0019888),0.38158883563893103,1.0524671544630646,0.4116997792494481,0.9986308773901434,1.0,22/53,24.31%,DMPK;CALM3;RCAN2;PPP2R2C;RCAN3;PPP1R2;PPP1R9B;PPP2R5E;PPP6R3;PPP1R16A;PPP2R5D;PPP2R5A;CALM1;ARPP19;IGBP1;PPP2R2B;CALM2;PPP2R2A;PPP4R4;PPP2R5C;PPP4R1;PPP2R2D
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4956100717261858,1.051563470456143,0.40988372093023256,0.997027114663462,1.0,5/10,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,syntaxin-1 binding (GO:0017075),0.42139750680710375,1.0515067744739433,0.41357234314980795,0.9924704589907701,1.0,7/22,16.55%,UNC13A;VAMP3;CPLX1;SNAP25;SYT1;DAPK1;NSF
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3418063956316495,1.0482336125477627,0.357,0.9992565315257007,1.0,94/346,21.26%,RNF157;CDC23;RNF138;MSL2;RNF8;UBE2S;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;SYVN1;RNF215;TRIM11;BRAP;FBXL14;PDZRN3;TNFAIP3;FBXO7;COP1;BARD1;TRIM56;RFFL;TRIM35;MYCBP2;RMND5A;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;RNF40;RNF168;RNF103-CHMP3;TRIM41;TRIM17;CUL4B;RNF11;CHFR;UBE2Z;MALT1;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;UBE2A;ANAPC11;ANAPC4;NEURL2;UBE2J1;CUL5;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;KLHL13;UBE2E1;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBE2L3;UBR5;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;PPP1R11;KLHL20;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;KLHL9;TRIP12;HECW2;CBLB;CNOT4
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3145462423122235,-1.0470662300025322,0.3688888888888889,0.9927865265413223,1.0,7/25,14.84%,TGFA;FER;TNK2;SNX2;PLSCR1;ARF4;HIP1
prerank,growth factor receptor binding (GO:0070851),0.35104971120817197,1.0447945429894225,0.3939075630252101,1.0,1.0,10/95,11.48%,FGF20;FGF9;FGF10;PIBF1;SDCBP;FRS2;EGF;KL;PDGFRA;CNOT9
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.49532053170767715,1.0445549228692659,0.4103299856527977,1.0,1.0,6/11,19.80%,PRMT6;PRMT5;PRMT1;PRMT8;PRMT2;CARM1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3873419924874668,1.0445317595160242,0.43123543123543123,0.9980490775481088,1.0,3/42,4.67%,CDKN2D;HEXIM1;CCNC
prerank,alpha-actinin binding (GO:0051393),0.4202919813427015,1.0438781353357345,0.43014705882352944,0.995738456233641,1.0,2/24,1.71%,PDLIM2;PDLIM7
prerank,AMP binding (GO:0016208),-0.41241866411809,-1.0418227825057398,0.3707165109034268,0.9955243023394305,1.0,9/11,42.68%,MPPED2;PRKAG1;PFKM;ACSS2;PRKAG3;PFKL;APRT;PFKP;PYGL
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.410713938630154,-1.03981930952756,0.41875,0.9883503649833378,1.0,9/10,56.85%,NOX1;CYBA;NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,myosin II binding (GO:0045159),-0.41974720998245907,-1.0387415239098685,0.39335180055401664,0.9783440017087774,1.0,6/10,30.85%,STXBP5;SHROOM4;TRIOBP;STXBP5L;SHROOM1;LLGL2
prerank,CARD domain binding (GO:0050700),-0.37418283840714556,-1.038614392646254,0.39338235294117646,0.965281821331761,1.0,7/14,22.71%,NOD1;CASP4;MAVS;CARD10;IRGM;CARD14;BCL10
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3626798703171353,1.037960276433278,0.4236186348862405,1.0,1.0,12/60,13.11%,MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;ROR2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.40256316685003257,1.0369701215278242,0.42632850241545894,1.0,1.0,9/30,18.94%,CARD16;PRDX5;XIAP;SPOCK1;UBE2Z;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.440988830826477,1.0362037482656619,0.44503311258278144,1.0,1.0,5/19,17.61%,CD24;NRG3;EGF;NRG1;ABI1
prerank,serine-type endopeptidase activity (GO:0004252),0.35524157178341553,1.0352784497997345,0.44193548387096776,1.0,1.0,10/80,17.07%,RHBDL3;PCSK5;PCSK2;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4696447804669383,1.0343234551675933,0.434654919236417,1.0,1.0,4/12,15.76%,PDE7B;PDE4A;PDE8B;PDE4B
prerank,Toll-like receptor binding (GO:0035325),-0.39488267855795844,-1.033786121942793,0.42,0.9679583740617413,1.0,3/11,10.17%,DAB2IP;UNC93B1;TOLLIP
prerank,I-SMAD binding (GO:0070411),0.4661360846716921,1.0337523638206134,0.4536376604850214,1.0,1.0,8/13,22.12%,SMAD9;TGFB1I1;SMAD6;SMURF1;TGFBR1;SMAD7;SMAD2;SMAD3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.30166602649302876,-1.0332017155323765,0.39705882352941174,0.9568712835812667,1.0,10/26,20.82%,ABCG2;SLC6A6;SLC16A2;SLC16A6;SLC16A1;SLC16A11;SLC5A6;SLC16A9;SLC16A4;SLC16A7
prerank,cell-cell adhesion mediator activity (GO:0098632),0.376512762289277,1.031717638463677,0.4468822170900693,1.0,1.0,14/42,21.54%,ANXA1;SIRPA;DSCAM;JAM3;BAIAP2;RAB10;CD47;NPTN;ANXA2;PLXNB3;CNTN2;NEXN;S100A11;PDLIM1
prerank,histone acetyltransferase activity (GO:0004402),-0.29503545850241336,-1.0293510311862024,0.35294117647058826,0.9575481944510426,1.0,11/30,19.34%,EPC1;KAT7;BAZ1A;KAT2B;MCM3AP;NAA40;EP300;KAT6B;BRCA2;KAT8;NAA60
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.39193035370702056,1.029272327783398,0.43457943925233644,1.0,1.0,8/35,12.36%,MMP12;TAF4;POU2F1;TBP;SMARCB1;PARK7;NPM1;HDAC1
prerank,titin binding (GO:0031432),0.462340905371296,1.028078180134006,0.44573082489146165,1.0,1.0,4/13,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,cytokine activity (GO:0005125),0.3394598660993446,1.027616141359887,0.43500511770726713,1.0,1.0,11/131,14.44%,WNT2B;WNT5A;IL34;BMP6;IL33;CXCL12;WNT4;BMP5;NRG1;TGFB1;SLURP1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.40695274522339264,-1.026847688517816,0.41002949852507375,0.9536170181922698,1.0,5/11,13.16%,ATP8B1;ATP10A;ABCA4;ATP11C;ATP11A
prerank,neuropeptide hormone activity (GO:0005184),-0.31727809720696365,-1.0248351644990121,0.4260089686098655,0.9479103782260196,1.0,19/22,65.03%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPY;NPFF;PNOC;NMB;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4687769737826075,1.0244449248950431,0.43484626647144947,1.0,1.0,2/12,2.24%,KDM4D;KDM7A
prerank,protein kinase activator activity (GO:0030295),0.36338772109335393,1.0241653296023474,0.45274725274725275,1.0,1.0,18/60,18.99%,INCENP;CALM3;TAOK1;DDX3X;STK11;CD24;GPRC5B;ALS2;IQGAP1;PARP16;NRG1;MAP2K2;DAXX;SPRY2;ABI1;CAB39L;CALM1;PRKAG2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4536409950583223,1.0198458655161176,0.43982808022922637,1.0,1.0,3/13,17.77%,DDT;EHHADH;ECH1
prerank,ATP hydrolysis activity (GO:0140603),0.3793221787758528,1.019536694121954,0.45164960182025027,1.0,1.0,8/41,12.16%,HSP90AA1;MYO19;DDX3X;ATP2B1;TOR1B;VCP;RHOBTB3;VPS4B
prerank,death receptor binding (GO:0005123),-0.3610477472613699,-1.0189394741238689,0.4334470989761092,0.9542482508623473,1.0,6/15,13.17%,DAB2IP;CASP8AP2;RIPK1;FEM1B;MADD;NGF
prerank,semaphorin receptor activity (GO:0017154),0.47334202849875623,1.0188483732493427,0.45170876671619614,1.0,1.0,3/11,8.09%,PLXNA2;NRP1;PLXNA1
prerank,microtubule binding (GO:0008017),0.335049108556736,1.0183140810600975,0.46277665995975853,1.0,1.0,57/222,21.52%,PSRC1;CFAP157;FSD1;CCDC61;CCDC170;REEP4;DNM1;WHAMM;MAPRE3;KIF3A;MDM1;RAE1;NEFH;ALMS1;CDK5;MTCL1;KIF3C;MACO1;CAMSAP2;GAS2L1;RMDN2;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;TPGS1;KIF5C;MAPT;MAP1LC3B;EML2;DNM1L;VAPB;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;CCDC88A;EML3;KIF20B;KRIT1;MAP6D1;RPS3;PAFAH1B1;KIF6;DCX;MAP6;MAP4K4;FGF13;CLASP2;MID2
prerank,sialyltransferase activity (GO:0008373),0.42376125324928043,1.0182143056485804,0.4610303830911493,1.0,1.0,5/20,8.55%,ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;ST3GAL5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.41411860379349225,-1.017878380999095,0.42857142857142855,0.9336723327338831,1.0,5/10,32.75%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.41411860379349225,-1.017878380999095,0.42857142857142855,0.9336723327338831,1.0,5/10,32.75%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,nucleosomal DNA binding (GO:0031492),0.4236320425536969,1.0169369967976036,0.4582798459563543,1.0,1.0,6/21,12.64%,SMARCC2;RBBP4;SMARCB1;MTA2;HDAC1;RCC1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4324647622451762,1.0156835206905774,0.46174863387978143,1.0,1.0,5/18,16.83%,FAR2;ALDH1A2;AKR1B10;FAR1;ALDH3A2
prerank,GABA receptor activity (GO:0016917),-0.32377344708273076,-1.015341068888008,0.3972602739726027,0.9301964068954077,1.0,7/21,21.34%,GABRB1;GABRG2;GPR156;GABRA5;GABRA4;GABRG1;GABRA1
prerank,potassium ion antiporter activity (GO:0022821),0.4378470517849096,1.0140672309129803,0.4747340425531915,1.0,1.0,4/15,15.89%,SLC24A5;SLC24A4;SLC9A7;SLC9A6
prerank,protease binding (GO:0002020),0.34443480718251057,1.0137118729782388,0.47210743801652894,1.0,1.0,27/99,20.97%,SELENOS;BIN1;ATP9A;SYVN1;CCBE1;TNFAIP3;CARD16;RFFL;BDKRB2;CHMP3;VCP;SART3;BCL2;COL1A2;PARK7;PSAP;F3;DERL1;TRIP4;SERPINE1;ANXA2;FLOT1;TIMP2;NFRKB;ITGAV;NTRK2;ITGB1
prerank,estrogen receptor binding (GO:0030331),-0.2782127717803536,-1.0126361055569928,0.41818181818181815,0.9273571171403313,1.0,6/32,5.09%,CNOT1;LATS1;LEF1;NCOA6;MED1;DCAF1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4399828170284244,1.011083637306864,0.4504881450488145,1.0,1.0,5/15,23.01%,ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1;ALDH2
prerank,RNA polymerase II complex binding (GO:0000993),-0.2794693239702243,-1.0102288020629078,0.4057142857142857,0.9236109538935223,1.0,11/32,15.15%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2;PCIF1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.38896853754281163,-1.0068851772833811,0.44694533762057875,0.9225647387933421,1.0,2/12,8.80%,STAT1;TRAP1
prerank,metal ion binding (GO:0046872),0.3237487799004327,1.0053282884890269,0.495,1.0,1.0,106/477,21.81%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;HMGCLL1;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;NUAK2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;ABL1;PPA2;RASGRP2;STK11;BRSK2;SPARC;RAP2A;ADGRV1;RCN3;SIK1;SPOCK1;CRACR2A;DHX36;CDH11;NUDT12;PITPNM3;ENPP2;BRSK1;NUDT3;IGFBP3;ENDOV;MCTP2;BNIP2;IQGAP1;ENPP1;TDP2;FBN1;SYT1;SPOCK2;HPRT1;GCLC;PAM;LRP1;EYA2;CDH18;EPHX2;SLIT1;SLIT3;DIS3L2;EFHD1;NT5C3A;ANXA2;TPPP;MAN1C1;OXSR1;APOE;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SRPK1;SCUBE1;CDC42BPB;TRIM27;CALM1;MTPAP;TPM4;IMPA1;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;EXD2;GSN;SYT11;SYT12;CDH10;SDF4;CALM2;TRIM26
prerank,GTPase regulator activity (GO:0030695),0.3301067817542786,1.0046301250118272,0.4969818913480885,1.0,1.0,69/212,21.97%,ELMOD1;MTSS2;TSC2;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;NRP1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;RANBP3L;SIRPA;RAP1GAP;ARRB1;ARHGAP42;RAP1GAP2;RABGAP1L;GPSM1;ARHGAP24;TBC1D20;RIC8B;USP6NL;RTKN;GPSM2;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;ARAP1;ADAP1;PDE6D;RABGAP1;ARHGAP29;IPO7;DNM1L;TBCD;ARHGEF6;ITGB1BP1;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;GPS2;ADGRB3;RANBP2;RANBP3;KRIT1;RALGAPB;DLC1;STARD13;RAB3GAP2;RALGDS;CHN1;NPRL2;PREX1;ARHGAP26;LLGL1;ARHGAP35;ARFGAP3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3464502184394141,1.004033897086471,0.4879074658254469,1.0,1.0,11/85,11.46%,LPL;LYPLAL1;PON2;PON3;PRDX6;GDPD3;AARS1;ENPP2;PGAP1;APMAP;TARS2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4107921936872977,1.0037943139813321,0.47388535031847134,1.0,1.0,5/22,8.82%,PRPF8;TNFAIP3;OTUD7A;SQSTM1;RNF168
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3069821449026916,-1.0035518337876441,0.4074074074074074,0.9215140114464375,1.0,6/21,9.65%,WASF2;PRRC1;EZR;PRKACA;AKAP9;AKAP7
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.40173864319829466,1.0024323290257844,0.4680306905370844,1.0,1.0,8/23,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,platelet-derived growth factor binding (GO:0048407),-0.38483669246072755,-1.0018075306690795,0.43788819875776397,0.9163247884164275,1.0,5/11,19.78%,COL5A1;COL6A1;COL4A1;PDGFA;COL1A1
prerank,single-stranded RNA binding (GO:0003727),0.3707254105487349,1.001183782478175,0.4805936073059361,1.0,1.0,8/43,12.58%,ILF3;DDX3X;CNBP;DHX58;LACTB2;SRA1;ENDOV;AGO3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.41892262923226087,1.0011568876454915,0.4881889763779528,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.41892262923226087,1.0011568876454915,0.4881889763779528,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,sterol binding (GO:0032934),0.35711626448610045,1.0003405881299883,0.4877232142857143,1.0,1.0,12/56,13.54%,SCAP;RORA;STARD5;ERLIN2;VDAC2;OSBPL11;SOAT1;INSIG1;PTCH1;STARD3;VDAC1;SIDT1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2716442729353432,-0.9984530978967566,0.4779874213836478,0.9160876262086877,1.0,16/37,26.39%,SLCO3A1;SLCO1C1;SLCO2A1;COX4I1;COX5A;COX8A;NDUFA4;SLC22A6;COX7A2L;COX6A1;SLC16A7;COX15;UQCR10;ATP13A3;UQCRQ;UQCR11
prerank,RNA methyltransferase activity (GO:0008173),0.41854236862708394,0.9963009021999286,0.48877146631439894,1.0,1.0,2/19,3.32%,TRDMT1;FBL
prerank,mRNA binding (GO:0003729),0.3240123868015578,0.9954970472297432,0.5095285857572718,1.0,1.0,74/249,21.46%,CPEB1;KHSRP;GNL3;SLBP;RBM4B;RBM47;PCBP4;ZFP36L1;DDX3X;SRSF5;IGF2BP2;FUBP1;SF3B1;CNBP;DCP1B;CELF2;CELF1;HNRNPK;DHX33;KHDRBS2;SRSF1;RNF40;PABPC4;RBMS3;DHX36;PUM3;HNRNPM;PABPC1;MYH10;HDLBP;RBFOX2;CSTF2T;SHFL;RC3H2;RBMS1;NUDT21;EIF4G2;RBMS2;YTHDF3;PARK7;HNRNPA0;MYEF2;HNRNPL;YTHDF1;TRA2B;LUC7L2;CSDC2;NOVA1;HNRNPA2B1;MRPL13;HNRNPLL;CELF5;DDX5;GRSF1;YTHDC1;EIF4G3;FMR1;ZC3H12C;LUC7L3;CPSF6;PCBP2;RSL1D1;SAMD4B;YTHDF2;RPS3;CSTF3;CIRBP;HNRNPU;GEMIN5;TPR;PTBP1;RPL7;ANGEL2;SRRM2
prerank,phosphate ion binding (GO:0042301),0.4785229331825742,0.9953764791547371,0.4872944693572496,1.0,1.0,1/10,3.77%,RPH3A
prerank,translation initiation factor activity (GO:0003743),-0.26845443152529236,-0.9936589604757778,0.44571428571428573,0.921402042930479,1.0,17/36,26.78%,EIF3E;EIF2S2;EIF2A;AGO2;EIF4E;EIF4A2;EIF2D;EIF3B;EIF5;EIF3K;EIF3I;EIF2B5;EIF2B2;EIF3D;EIF3L;EIF2B4;MTIF3
prerank,nucleotidyltransferase activity (GO:0016779),-0.3238239493002327,-0.989713807719143,0.4473684210526316,0.9227673926674154,1.0,12/19,41.82%,NUDT5;TENT2;REV1;PAPSS2;TUT1;TUT4;TERT;YRDC;CGAS;TUT7;CRPPA;MOCS3
prerank,iron ion binding (GO:0005506),0.3533196437963433,0.9870522472624319,0.5033860045146726,1.0,1.0,14/48,20.47%,KDM7A;ISCA2;AGMO;ALKBH3;EGLN2;ETHE1;DNAJC24;HEPH;FTO;ABCE1;ALKBH1;TET1;NFU1;FTH1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4753175330324171,0.9850956131950587,0.5067264573991032,1.0,1.0,3/10,15.46%,CASP7;CASP9;CASP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.4404531749031415,0.9837512595291638,0.4943820224719101,1.0,1.0,4/14,21.60%,SLC7A11;SLC1A3;SLC1A2;SLC38A7
prerank,transition metal ion binding (GO:0046914),0.3151152212766242,0.9781223200203844,0.5925925925925926,1.0,1.0,96/397,21.53%,GALT;MMP12;ADH5;XPNPEP3;SMPDL3B;NQO2;SIRT2;KDM7A;ISCA2;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;GALNT4;TIMM13;DHX58;LACTB2;ABL1;ZEB1;TARS1;GPC1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;POMGNT1;FAM20C;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;AGMO;ENPP2;CUTA;KDM2B;COX17;ZCCHC4;PAPPA;ENPP1;PARK7;SOD2;SOD3;LANCL1;TDP2;ZMYM2;PAM;ADAMTS3;ETHE1;DNAJC24;BBOX1;GLRA1;LACC1;PPM1M;HEPH;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;MOXD1;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;ABCE1;SLC11A2;SMPD1;TIMP2;TET1;MTPAP;KLF4;IMPA1;NFU1;MMP16;FTH1;CTCF;PTGR2;ZBTB32;TAB3;EXD2;TES;CBLB;ME1;COMMD1;ATOX1
prerank,clathrin adaptor activity (GO:0035615),-0.33632159749945184,-0.9761519606035328,0.46179401993355484,0.9539503099203512,1.0,5/15,18.43%,AP2A2;HIP1;AP1M1;AP2M1;LDLRAP1
prerank,nuclear localization sequence binding (GO:0008139),0.4234233550519186,0.9740960350054227,0.5087719298245614,1.0,1.0,8/18,20.31%,KPNA3;BRAP;KPNB1;NUP214;TNPO1;NUP153;KPNA1;CABP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3955404863160727,0.9738114530776631,0.514102564102564,1.0,1.0,1/22,0.41%,DUSP18
prerank,methylated histone binding (GO:0035064),0.3433418004576153,0.9715391444886133,0.5293466223698782,1.0,1.0,15/62,18.61%,CBX8;KDM7A;CHD8;PHF1;CHD5;DPF2;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,histone acetyltransferase binding (GO:0035035),-0.3154742224786921,-0.9698373483310431,0.45652173913043476,0.9627645886426814,1.0,5/21,8.90%,MEF2A;KANSL1L;STAT1;HIF1A;TP53
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.37383050956716873,0.9686497933103586,0.5301775147928994,1.0,1.0,9/31,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.3857017323625408,-0.9681023066619266,0.4952681388012618,0.956986506036843,1.0,9/11,61.45%,HCN2;HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,ATPase activator activity (GO:0001671),-0.30892244254713735,-0.9674986103467955,0.4921259842519685,0.9482439511462046,1.0,8/20,22.76%,ATP1B3;DNAJC15;DNAJC1;ATP1B1;DNAJA2;DNAJB2;DNAJA1;AHSA1
prerank,phospholipase activity (GO:0004620),0.3405085498087024,0.9671297218492546,0.5523504273504274,1.0,1.0,15/67,21.23%,LPL;GPLD1;SMPD2;LYPLAL1;PRDX6;GDPD3;PITPNM3;ENPP2;SMPD4;DDHD2;PNPLA7;GDE1;SMPD1;ABHD16A;PLCL1
prerank,metallocarboxypeptidase activity (GO:0004181),0.3859906379380906,0.96676576664883,0.5330012453300125,1.0,1.0,6/26,19.22%,CPXM1;AGBL3;PEPD;CPXM2;AGBL4;AGTPBP1
prerank,U6 snRNA binding (GO:0017070),0.4323222447981575,0.9660339342214257,0.5177809388335705,1.0,1.0,3/14,11.06%,LSM7;PRPF8;SART3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.45275669782315553,0.9651225114471227,0.5266955266955267,1.0,1.0,3/11,15.46%,CASP7;CASP9;CASP2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.28858306093234765,-0.9648505365308317,0.49746192893401014,0.9462913690418987,1.0,9/27,15.29%,SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC25A14;SLC5A5
prerank,leucine zipper domain binding (GO:0043522),0.461949780991322,0.9646255240327248,0.5295031055900621,1.0,1.0,3/10,15.37%,MRTFA;DDIT3;PAWR
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.323389012591094,-0.9636215732301573,0.49808429118773945,0.9399869430108936,1.0,9/16,36.89%,SLC25A13;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,thioesterase binding (GO:0031996),0.448150810342492,0.9598295421296711,0.524517087667162,1.0,1.0,1/11,2.78%,RAC1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3600821735719071,-0.9565053240309128,0.5345911949685535,0.9503192272768506,1.0,5/12,32.75%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,LRR domain binding (GO:0030275),0.42728836421282257,0.9559373266091882,0.540084388185654,1.0,1.0,4/14,15.37%,MRTFA;DDIT3;ROBO1;PAWR
prerank,triglyceride lipase activity (GO:0004806),0.4027711641144002,0.9555279875374012,0.5399737876802096,1.0,1.0,1/20,0.96%,LPL
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.372834546824002,-0.955230464820965,0.5382262996941896,0.944292195322039,1.0,9/11,62.74%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3823390452243708,-0.9549545026244807,0.5115606936416185,0.9356308289011396,1.0,6/10,19.34%,NAA40;EP300;MSL3;BRCA2;KAT8;NAA60
prerank,hyaluronic acid binding (GO:0005540),0.45834832989167296,0.9533048527288884,0.5469208211143695,1.0,1.0,1/10,1.16%,LYVE1
prerank,serine-type peptidase activity (GO:0008236),0.3204433056352205,0.9518388690500401,0.5732217573221757,1.0,1.0,11/96,17.07%,RHBDL3;PCSK5;PCSK2;HTRA3;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,retinoid X receptor binding (GO:0046965),-0.3648532999792059,-0.9517190242680987,0.5163398692810458,0.9348321884064962,1.0,7/11,28.02%,NCOA6;RARG;MED25;NRIP1;PPARG;NR4A2;ARID5A
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.39064235824946053,0.9515076576361444,0.5365535248041775,1.0,1.0,6/20,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,RNA binding (GO:0003723),0.30353242915857676,0.9498314943929236,0.77,1.0,1.0,305/1321,18.55%,ILF3;FASN;SRP19;NHP2;KHSRP;HEXIM1;AFF2;BICC1;RAVER2;LSM6;EXOSC1;CDC42EP4;EXOSC3;APTX;GNL3;TARBP2;YARS1;DHX40;ANXA7;DGCR8;DDX17;NOP9;PSMD4;LSM7;DNM1;TRMT2A;DDX18;TBRG4;TOE1;SUGP2;CHERP;HMGB3;DDX19B;SLBP;EBNA1BP2;RBM4B;PARP1;FAM50A;HSP90AA1;EXOSC7;EXOSC2;RBM3;PRKRIP1;TRUB2;FBL;U2AF1;SRSF2;DIMT1;RBM47;PCBP4;LRRC47;ANP32A;NOP56;RPL22L1;ZFP36L1;PRPF8;ZCCHC8;SRSF12;DDX3X;PSPC1;YARS2;DHX15;RAE1;POLR2B;CDK13;SRSF5;SLTM;SPATS2;TBCA;IGF2BP2;FUBP1;DRG2;SF3B2;SF3B1;DHX30;STIP1;DCN;CNBP;MTCL1;RBM39;DCP1B;CELF2;DHX58;LACTB2;PUS10;ARL6IP4;CARS1;DHX8;SARS2;BARD1;ZC3H4;NOL12;SRSF3;CELF1;TRIM56;HNRNPK;AKAP8L;FUS;MPHOSPH10;TIA1;RTF1;SRSF9;DHX33;CCT6A;CKAP4;HADHB;IFIT3;SF3A1;WRAP53;AARS1;KPNB1;KHDRBS2;DDX46;PEF1;RCAN3;NFX1;PRPF6;SRSF1;FNDC3B;SRP9;TBL2;EIF1B;UBA1;GCN1;BUD23;MDH2;WDR6;USP10;EPRS1;RBM18;XRCC6;PABPC4;KIN;RCC1L;HNRNPD;RBMS3;DHX36;PPP1CC;PPIB;MRPL21;PUM3;MRPL10;RBM34;LIN28B;CPSF7;HNRNPM;VCP;NOL7;ANKHD1;PUS7;PABPC1;PSIP1;NKRF;ZC3H7B;YWHAG;MRPL1;ESF1;RPL35A;RPS25;MTREX;MYH10;TOP1;RBM10;HDLBP;RBFOX2;ZC3H14;ENDOV;SART3;CSTF2T;SHFL;SARS1;RC3H2;MAZ;RPS15;EIF4E2;RBMS1;MYO5A;YY1;TRMT1;JAKMIP1;NUDT21;EIF4G2;DYNC1LI1;RBMS2;ATXN2L;NEMF;PTCD2;YTHDF3;DHX16;FLNB;PARK7;EIF1;EIF1AX;NPM1;CPSF3;TIAL1;HNRNPA0;CFAP20;RPL9;AGO3;PEG10;RACK1;MYEF2;HNRNPH3;PRMT1;DHX57;SETX;SRP68;RBM45;HNRNPL;MRPL3;GSPT1;TLR3;METAP2;YTHDF1;TRA2B;LUC7L2;SIDT1;RPP30;C1D;LRP1;SUCLG1;RPL4;SND1;SCAF4;KHDC4;FAM98A;TUBA1B;MAPT;CSDC2;BMS1;NOVA1;ROCK2;CHCHD1;HNRNPA2B1;RBM26;PRPF40A;HELB;USO1;BCLAF1;XRN1;MRPL13;RP9;ISG20L2;HNRNPLL;NUCKS1;CELF5;SPTBN1;TNPO1;HSPD1;RPL7L1;CCDC9;TFB1M;DDX5;GRSF1;AHNAK;SAFB2;HNRNPDL;ZC3HAV1;YTHDC1;NUDT16L1;SNW1;LAS1L;DDX19A;EIF4G3;ANXA2;DNAJC21;FMR1;UBE2L3;THRAP3;RPL23A;OAS2;MSI1;TOP3B;ZC3H7A;MTDH;ZC3H12C;MRPL15;DHX34;PTCD1;SON;DHX29;SRRM1;PNISR;BCCIP;NSA2;FASTKD1;PRPF40B;LUC7L3;CPSF6;RBM27;ZC3H18;PCBP2;MAP4;TENT5A;SMG7;ASS1;BRIX1;MECP2;RBM22;HLTF;NOL4;SRPK1;NONO;BAG4
prerank,amyloid-beta binding (GO:0001540),0.3322775017258625,0.9495329280265696,0.569327731092437,1.0,1.0,18/79,18.62%,FCGR2B;PFDN4;EPHB2;GRIN1;ATP1A3;VBP1;GRIN2A;LRPAP1;PFDN1;GRIA1;LRP1;GRIA2;HSPG2;ITM2B;APOE;PFDN2;SORL1;ITM2C
prerank,zinc ion binding (GO:0008270),0.30648033805153024,0.947667948981911,0.6629889669007021,1.0,1.0,67/293,21.25%,GALT;MMP12;ADH5;SMPDL3B;NQO2;SIRT2;KDM7A;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;TIMM13;DHX58;LACTB2;ZEB1;TARS1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;ENPP2;KDM2B;ZCCHC4;PAPPA;ENPP1;LANCL1;ZMYM2;PAM;ADAMTS3;DNAJC24;BBOX1;GLRA1;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;SMPD1;TIMP2;TET1;KLF4;MMP16;CTCF;PTGR2;ZBTB32;TAB3;TES;CBLB
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3044545249020302,0.9472223725978541,0.722,1.0,1.0,100/731,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;PRMT5;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3463678888138885,-0.9465881070613965,0.5346534653465347,0.9402260118799874,1.0,3/12,9.73%,SLC9A2;LETM1;SLC9B2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3041366570411889,0.9462477980352483,0.744,1.0,1.0,168/831,20.84%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;FOXM1;ZBTB48;POU5F2;NFKB1;ZNF25;ZBTB46;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;TFDP1;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;TBP;ZNF35;ZIC3;CASZ1;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;NFX1;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;RBL2;HOXB8;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;PEG3;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383;PROX2;FOXJ3;EBF1;ZIC2;TRPS1;ESRRG;BCL6;SOX5;RFX3;NR2C2;SATB1;TCF7L1;TCF3;FOXC2;CIC;GTF2IRD1;MAF;HOXC8;CLOCK;KDM6B;THRAP3;ZFP37;SOX13;ZBTB41;OSR1;ZFP90;TCF7;NFXL1;NSD1;MEIS2;RELB;ZNF177;CUX1;BCL11B;CHD2;FOXD1;KLF13;SOX4;ZIC4;RPS3;KDM6A;MITF;KLF4;GABPA;NFIA;PRDM15;DNMT3A;E2F6;PKNOX1;GLIS3;TBPL1;HDX;HNRNPU;CTCF;ZNF219;CREB5;ZBTB32;MYNN
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.30303865715673334,0.9429652522462376,0.74,1.0,1.0,99/732,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;FOXN3;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4286018079469286,0.9422599405612262,0.5338235294117647,1.0,1.0,3/12,14.04%,PIK3R1;FRS2;BLNK
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3302823354260188,-0.9407957977041128,0.5103448275862069,0.9472893220457829,1.0,3/13,9.73%,SLC9A2;LETM1;SLC9B2
prerank,MHC protein binding (GO:0042287),-0.3055482479539453,-0.9400654000774765,0.5534351145038168,0.9400189273996353,1.0,8/20,31.84%,TAPBP;TAP2;ATP5F1B;ABCB9;CD81;TAP1;TUBB4B;CD74
prerank,acetylcholine receptor activity (GO:0015464),-0.2940668249833633,-0.9377821003592671,0.5291479820627802,0.9375631052472295,1.0,3/22,14.43%,CHRM3;CHRFAM7A;CHRNA7
prerank,GTPase activity (GO:0003924),0.30510699624667853,0.9373135122612019,0.6532663316582915,1.0,1.0,42/192,18.38%,GPN2;ATL1;GBP3;DNM1;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;GNAS;DRG1;RHOBTB3;RAB3B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;GNAQ;MRAS;RRAS2;RAB6A;ARL8B
prerank,endodeoxyribonuclease activity (GO:0004520),0.3909550377579315,0.9354019428721991,0.5755968169761273,1.0,1.0,6/20,19.43%,APLF;ENDOV;MRE11;RAD50;RBBP8;RPS3
prerank,GTPase activator activity (GO:0005096),0.30553091247584857,0.9345801406892096,0.6926926926926927,1.0,1.0,79/313,18.77%,ELMOD1;MTSS2;TSC2;SH3BP5;TBC1D7;SGSM3;RUNDC1;NUCB2;RAP1GDS1;RGS10;ARHGEF10;NRP1;GAPVD1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;RANBP3L;KALRN;MYCBP2;RAP1GAP;ARRB1;ARHGAP42;DOCK8;RAP1GAP2;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;RABGAP1L;VAV2;ARHGAP24;TBC1D20;DENND4C;DENND5A;RIC8B;USP6NL;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;MON1A;ARAP1;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;ADAP1;EEF1B2;RABGAP1;ARHGAP29;DNM1L;CYTH1;FARP2;DNMBP;TBCD;ARHGEF6;EPS8L1;DENND6A;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;ADGRB3;RANBP2;RANBP3
prerank,GTPase inhibitor activity (GO:0005095),-0.3341806247299317,-0.9335438325820868,0.5117845117845118,0.9400323447163241,1.0,8/13,24.32%,SLIT2;TNK2;CPEB2;IPO5;IQGAP2;CDC42SE1;ARL2;RHOH
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.31814206221064717,-0.9309914309852683,0.5591397849462365,0.9383598570419922,1.0,4/17,5.50%,ATP8B1;ATP10A;PITPNA;PITPNC1
prerank,GABA receptor binding (GO:0050811),0.4386136737851793,0.9308442758167496,0.5765765765765766,1.0,1.0,3/11,15.81%,PLCL2;JAKMIP1;TRAK1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3302994259775752,0.9303722530363303,0.5788288288288288,1.0,1.0,7/51,10.92%,SLC4A4;SLC35D2;SLC22A4;ANKH;SLC20A2;CLCN4;SLC22A8
prerank,proton transmembrane transporter activity (GO:0015078),-0.24511652056297348,-0.9266229172657052,0.6137931034482759,0.9413434573804718,1.0,16/39,28.71%,SLC33A1;CLCN3;COX4I1;COX5A;COX8A;CTNS;NDUFA4;COX7A2L;COX6A1;DMAC2L;COX15;UQCR10;UQCRQ;UQCR11;NNT;COX5B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4288390386017093,0.9263136739672401,0.5980392156862745,1.0,1.0,2/13,11.52%,BMP6;BMP5
prerank,Tat protein binding (GO:0030957),-0.3725501761169926,-0.9261609106034263,0.5626911314984709,0.9340627791979311,1.0,3/10,8.03%,MDFIC;ACTB;CTDP1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3522841724570487,-0.9255778762410013,0.5496688741721855,0.9271432587268736,1.0,3/12,8.71%,BACE2;BACE1;DDI2
prerank,calcium:sodium antiporter activity (GO:0005432),0.4363643082363572,0.9246965118551855,0.5641025641025641,1.0,1.0,2/10,8.64%,SLC24A5;SLC24A4
prerank,ATP binding (GO:0005524),0.3025667576601123,0.9233410765494835,0.6973947895791583,1.0,1.0,60/266,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,cGMP binding (GO:0030553),-0.3622542950544674,-0.922334471772957,0.5462962962962963,0.9278360976734192,1.0,1/11,0.78%,PDE5A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.32453125060963856,-0.9221900151751508,0.5435540069686411,0.9197788943263784,1.0,6/15,12.36%,KMT2C;WDR82;RBBP5;SETD1B;SETD3;WDR5
prerank,mRNA methyltransferase activity (GO:0008174),0.4275425533572873,0.9218634768776316,0.5804511278195489,1.0,1.0,1/12,0.77%,TRMT61B
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.34182166250686086,-0.9215229690560888,0.576271186440678,0.9134380189205763,1.0,6/13,22.30%,SLC7A1;SLC7A6;SLC7A7;SLC15A4;SLC66A1;SLC38A5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.34407293136185474,-0.9209831472702901,0.5641025641025641,0.9066825430613569,1.0,6/12,22.25%,CNOT1;NOCT;PARN;CNOT8;CNOT7;CNOT2
prerank,tau protein binding (GO:0048156),0.3418359198033422,0.9197692000900681,0.5942196531791908,1.0,1.0,12/40,18.71%,BIN1;HSP90AA1;STUB1;TAOK1;CDK5;BRSK2;BRSK1;ROCK2;PPP5C;PPP2CB;APOE;PRKAA1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.42075933521480097,0.9184233290124918,0.5647226173541963,1.0,1.0,3/12,14.45%,SULF1;ARSG;ARSB
prerank,androgen receptor binding (GO:0050681),0.3707613820178959,0.9178080837762681,0.5820707070707071,1.0,1.0,9/25,19.08%,WIPI1;TGFB1I1;PRPF6;PARK7;DDX5;SNW1;DAXX;NSD1;PRMT2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.30408986940496774,0.9175395619637107,0.6924623115577889,1.0,1.0,42/181,19.94%,HDAC3;TEAD3;DUSP26;BBS10;SMARCD3;COMMD6;MIER2;TAF4;TCF7L2;BBS7;TBP;TACC1;ARNT;SMARCB1;HDAC5;TTC8;CDK5RAP3;HDAC4;PRRX1;RBL2;ATF2;TAF6;JUP;RBPJ;MTA2;NPM1;TADA3;HDAC1;PIAS3;TCF3;FAF1;SNW1;TRIP4;MTDH;ANXA4;RBBP8;ATN1;NCOR2;NCOA3;KLF4;PIAS1;MIER1
prerank,BMP receptor binding (GO:0070700),0.4288462692502969,0.9169859287600465,0.607898448519041,1.0,1.0,2/12,11.52%,BMP6;BMP5
prerank,TBP-class protein binding (GO:0017025),-0.30074297068053696,-0.916486435219611,0.6047619047619047,0.9099783973103437,1.0,10/21,23.64%,THRA;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36967966824288007,-0.9160385829780605,0.556923076923077,0.9031979362857278,1.0,2/10,7.61%,ADARB2;APOBEC1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.2888984793314197,-0.9145724077418181,0.5826086956521739,0.8989293292692053,1.0,3/21,14.43%,GRM1;CHRFAM7A;CHRNA7
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2987486657765644,0.9143039054873069,0.7399598393574297,1.0,1.0,67/269,18.55%,PTPRN;UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;HGS;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CDK5RAP3;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;TRIP4;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,voltage-gated anion channel activity (GO:0008308),0.4023114499258967,0.9139958005286707,0.5934844192634561,1.0,1.0,4/15,13.34%,CLCN2;VDAC2;CLCN4;VDAC1
prerank,MAP kinase kinase activity (GO:0004708),0.3998284425006435,0.9133856129327306,0.5676795580110497,1.0,1.0,6/15,23.76%,PAK3;MAP2K2;MAP2K7;MAP2K3;MAP2K1;MAP2K6
prerank,cholesterol transfer activity (GO:0120020),-0.30969402318372874,-0.912512828396422,0.5905797101449275,0.8966947558446391,1.0,3/16,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,phosphatase binding (GO:0019902),0.30674944091954415,0.9117046851514898,0.6453608247422681,1.0,1.0,34/105,22.67%,TSC2;EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;DLG3;SIRPA;RCAN3;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;MAGI2;RACK1;ANAPC4;TRPC4AP;STX17;MTMR4;JAK1;TERF2IP;ANAPC5;KIFAP3;SYTL2;SPTBN4;SMAD2;TRAF2;CNST;SMAD3;ITGA1;MAP2K7
prerank,ephrin receptor binding (GO:0046875),0.3837740932959341,0.9113345236305505,0.6046814044213265,1.0,1.0,6/21,20.59%,ABL1;EFNB3;EFNB2;CBL;LYN;CHN1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.37653032946628795,-0.9111506719016249,0.6052631578947368,0.8926061624130386,1.0,4/10,20.27%,NAA15;NAA25;NAA60;NAA80
prerank,receptor tyrosine kinase binding (GO:0030971),0.3210096111013986,0.9095949293613276,0.6136114160263447,1.0,1.0,12/56,14.97%,PIK3R1;SQSTM1;FRS2;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,lipoprotein particle binding (GO:0071813),0.3786211522379279,0.9071314284070353,0.6023622047244095,1.0,1.0,4/20,17.95%,LPL;MAPT;HSPD1;SORL1
prerank,N-methyltransferase activity (GO:0008170),0.3773305076109837,0.9067990233034365,0.5852713178294574,1.0,1.0,7/20,18.42%,DIMT1;NNMT;ZCCHC4;TRMT1;PRMT1;TFB1M;METTL5
prerank,chemorepellent activity (GO:0045499),0.3638985799303471,0.905551739571078,0.6084183673469388,1.0,1.0,6/25,15.56%,EPHA7;NRG3;SEMA3D;NRG1;SEMA3E;SEMA3A
prerank,protein heterodimerization activity (GO:0046982),0.29790865965919233,0.9055341334775842,0.717741935483871,1.0,1.0,38/178,17.71%,LSM6;BAX;BMP6;USF1;XBP1;SAE1;FZD9;FBXO7;TENM3;TCF4;BARD1;ARNT;RRAGA;GTF2A2;ATP1A2;PEF1;BUD23;BDKRB2;DDIT3;SDCBP;YWHAH;PRMT5;KATNB1;TPM1;PIK3R2;BCL2;ADD2;RCC1;ZHX2;TENM4;TCF3;VAPB;AGTR1;FMR1;EXT2;MICU2;MTTP;QTRT2
prerank,ferrous iron binding (GO:0008198),0.36765856533521935,0.9051311070642535,0.612565445026178,1.0,1.0,7/21,20.47%,ALKBH3;EGLN2;DNAJC24;HEPH;FTO;ALKBH1;FTH1
prerank,cell adhesion mediator activity (GO:0098631),0.36376864661312214,0.903602844701946,0.6153846153846154,1.0,1.0,8/24,20.32%,SIRPA;DSCAM;JAM3;CD47;NPTN;PLXNB3;CNTN2;NEXN
prerank,adenyl ribonucleotide binding (GO:0032559),0.2944938796674849,0.9028335701682283,0.748,1.0,1.0,64/291,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;PDE4A;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;GCLC;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;PDE10A;PDE4B;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4328866679850708,0.9020115519568382,0.6045801526717557,1.0,1.0,2/10,8.00%,RENBP;GALE
prerank,cation channel activity (GO:0005261),0.30475954410196043,0.9019944238841742,0.6663190823774765,1.0,1.0,10/94,9.53%,PKD2L2;NALCN;SLC24A5;TMEM63A;GRIN1;TMEM63C;CALHM2;SLC24A4;TRPM3;KCNQ4
prerank,phospholipase binding (GO:0043274),0.41306698161361216,0.9010015957295745,0.612094395280236,1.0,1.0,4/13,20.16%,PDPK1;BLNK;PAFAH1B1;ARHGAP6
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.34499606625848794,0.9006456944526129,0.6135831381733021,1.0,1.0,9/34,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3886321941898118,0.9004446562612426,0.6099865047233468,1.0,1.0,3/15,9.16%,HS2ST1;NDST2;HS6ST2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.34160957387071555,0.8986391179065172,0.6188725490196079,1.0,1.0,11/34,20.72%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.34160957387071555,0.8986391179065172,0.6188725490196079,1.0,1.0,11/34,20.72%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,RNA stem-loop binding (GO:0035613),0.40932927300928923,0.8983693581927588,0.6035767511177347,1.0,1.0,5/12,16.78%,DDX3X;EPRS1;MYH10;RC3H2;FMR1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.2506530521144417,-0.897863425989327,0.6703910614525139,0.9168929779679919,1.0,12/32,28.23%,SLC6A6;SLC3A2;SLC6A9;SFXN2;SLC36A4;SLC43A2;SLC38A5;SLC1A4;SFXN3;SLC36A1;SLC43A1;SLC6A7
prerank,methylation-dependent protein binding (GO:0140034),0.32047610223788936,0.8975273298186575,0.6357541899441341,1.0,1.0,13/57,18.61%,CBX8;KDM7A;CHD8;PHF1;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,Wnt-activated receptor activity (GO:0042813),0.40173279137808876,0.8971041262570254,0.6111111111111112,1.0,1.0,2/15,4.16%,FZD9;FZD3
prerank,protein homodimerization activity (GO:0042803),0.2881332723259883,0.8968951088809463,0.839,1.0,1.0,107/589,16.99%,TNNC1;XPNPEP3;LPL;CAMK2B;NQO2;BAX;TARBP2;CACYBP;DGCR8;GBP3;TSC2;CLN6;DCK;PIP4K2B;RAB11FIP4;HSP90AA1;RNF8;STUB1;PAXX;USF1;NR2F2;FGFR2;FGFR1;WARS1;ERP29;GLIPR2;MAD2L1;GLB1;FZD9;YARS2;ST3GAL2;PON3;SNF8;TKT;TENM3;MTCL1;SRGAP2;SRM;BARD1;SNX6;ARNT;ZBTB7B;RRAGA;GTF2A2;ZBTB38;ZDHHC3;HSD17B4;RAP1GAP;GALE;HM13;RDH5;DDIT3;TRIM9;EPRS1;RNF40;GNPTG;GDNF;TPM1;JUP;DPY30;PTH1R;BCL2;SARS1;PDGFRA;IRF3;ALS2;TARS2;CNOT9;CAMK2D;NUDT21;NACC2;CARNMT1;ENPP1;PARK7;VPS4B;CAMK2G;SOX6;STARD3;NPM1;ADD2;RACK1;HARS1;FBLN5;PIP4K2A;PEX7;PSAP;ZHX2;NRBP1;ACSL6;EPHX2;ABCB7;DNM1L;DPYD;TENM4;TCF3;VAPB;ABCD2;PRMT8;CHEK2;NUDT16L1;MAPK4;TERF1;TPPP;FMR1;ALDH3A2;STK25;EXT2
prerank,cytokine receptor binding (GO:0005126),0.30398997815408957,0.8964631301608337,0.6765015806111696,1.0,1.0,19/83,24.49%,IL34;DDT;CXCL12;IL22;PIBF1;SDCBP;PRLR;USP15;PXDN;IL1RAP;CCL25;JAK1;TGFBR3;SMAD2;SMAD3;IL18;FKBP1A;JAK2;TRAF6
prerank,DNA binding (GO:0003677),0.28830602400193744,0.8961873478762014,0.884,1.0,1.0,130/694,18.35%,ILF3;CAMTA2;MMP12;POU6F1;SP7;APTX;DNASE1L2;MYRF;RNF138;HMGB3;NTHL1;ZEB2;CREBZF;USF1;NR2F2;AIFM2;ZNF8;XBP1;RORA;CARF;DDX3X;TAF4;MPG;CHD8;SDE2;POU2F1;RFX5;SLTM;FUBP1;CDK9;PALB2;TCF4;TCF7L2;TFCP2;FBH1;CNBP;IRF1;MLH1;SPO11;ABL1;DDB1;PHF1;ZNF35;TDP1;ZIC3;ARNT;RTF1;ZNF711;SMARCB1;TEAD1;SNAPC4;FANCG;TSHZ2;SOX9;DDIT3;XRCC6;KIN;DHX36;HDAC4;APLP2;ARID4A;CUL4B;RNF11;SAP30L;CALCOCO1;PSIP1;TOP1;DCLRE1A;KDM2B;APP;TAF6;RBPJ;ENDOV;BCL2;RC3H2;RPS15;IRF3;RBMS1;YY1;SMARCA1;E2F3;BRIP1;PARK7;SOX6;CEBPG;TDP2;PMS2;SETX;CBFB;CENPC;C1D;FOXJ3;MAPT;ZIC2;CAMTA1;BCL6;BCLAF1;ZNF292;XRN1;KMT2D;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;TCF3;NUPR1;SSBP2;FOXC2;HSPD1;SAFB2;BCLAF3;CLOCK;RAD50;CCNT1;TERF1;MBD1;THRAP3;SOX13;HP1BP3;TOPORS;NABP2;TOP3A;PCBP2;MEIS2;HMCES;RBBP8;MECP2;CUX1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.35689179010795885,-0.8957183298060648,0.5865384615384616,0.9146265838920162,1.0,10/11,64.34%,DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;DDAH1;PADI3;PADI6
prerank,microtubule plus-end binding (GO:0051010),-0.284548649317579,-0.8956726319863486,0.6126126126126126,0.9071906856822636,1.0,5/20,13.15%,DST;CLIP1;MAPRE1;TTBK2;DCTN1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.24618997553384436,-0.8945134373276827,0.6339869281045751,0.9026621483313271,1.0,12/38,18.43%,SORBS1;IRS1;NCK1;LRRK2;SPAG9;AXIN1;SHANK3;SHANK2;CARD10;GRIP1;SH2B3;LDLRAP1
prerank,MAP kinase activity (GO:0004707),0.39206573717824833,0.8943277097187399,0.6266094420600858,1.0,1.0,3/14,16.36%,MAPK9;MAPK6;MAPK4
prerank,ribosomal small subunit binding (GO:0043024),0.3820288682329727,0.8943024770704896,0.6085790884718498,1.0,1.0,6/17,18.76%,DDX3X;EIF1B;EIF1;NPM1;DHX29;ABCE1
prerank,palmitoyltransferase activity (GO:0016409),-0.25410022816496997,-0.892843499453561,0.6188118811881188,0.8992054890610849,1.0,12/28,26.75%,ZDHHC20;ZDHHC5;ZDHHC15;HHAT;GOLGA7;ZDHHC13;ZDHHC8;ZDHHC7;YKT6;ZDHHC16;ZDHHC4;ZDHHC24
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.28090389342368577,-0.8921731253995703,0.6493506493506493,0.8935141359771672,1.0,17/21,62.74%,CHRNA7;GLRB;P2RX7;CHRNB1;P2RX4;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.378704317945988,0.8918488248048746,0.6159895150720839,1.0,1.0,6/18,21.54%,ANXA1;BAIAP2;RAB10;ANXA2;S100A11;PDLIM1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2898220814401381,0.8916594356942441,0.7725450901803608,1.0,1.0,52/248,18.75%,GPN2;ATL1;GBP3;DNM1;HSP90AA1;MYO19;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;KIF3C;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;ATP2B1;GNAS;DRG1;TOR1B;VCP;RHOBTB3;RAB3B;VPS4B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;ABCD2;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;DHX29;GNAQ;MRAS;RRAS2;RAB6A;ARL8B;KIF20B
prerank,SUMO transferase activity (GO:0019789),0.38847021766491563,0.8910487886399228,0.633423180592992,1.0,1.0,6/16,19.91%,HDAC4;PIAS3;TOPORS;MDM2;RANBP2;PIAS1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2905168369367739,0.8888232794445168,0.7841365461847389,1.0,1.0,63/254,18.55%,UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,alpha-tubulin binding (GO:0043014),0.3462148760059518,0.8885257287081894,0.6339950372208437,1.0,1.0,9/31,19.92%,ARL4C;TAOK1;DIP2B;OFD1;PACRG;ARL8B;DNAL1;DLEC1;INO80
prerank,ATPase binding (GO:0051117),0.3091224633849513,0.8881669557547356,0.6721311475409836,1.0,1.0,12/71,12.68%,TMTC4;SELENOS;FBL;ATP6V0A2;SYVN1;ANK1;SNX10;BRSK2;ATP6V1G1;TCIRG1;PTPN3;ATP6V0A4
prerank,channel activity (GO:0015267),0.33297486229293977,0.8878725431739949,0.6386651323360184,1.0,1.0,4/41,14.55%,BAX;SLC14A1;BCL2;AQP4
prerank,nuclear export signal receptor activity (GO:0005049),-0.34745056086913334,-0.8853445717532529,0.6300940438871473,0.9024097896412256,1.0,3/11,10.52%,EIF4ENIF1;XPO5;NUP42
prerank,phosphatidic acid binding (GO:0070300),0.37120168557960553,0.885257177155964,0.6440903054448871,1.0,1.0,2/19,2.84%,GSDMD;PLEKHN1
prerank,insulin-like growth factor I binding (GO:0031994),-0.3170197415756577,-0.8825067273182743,0.5698924731182796,0.9016852522464617,1.0,2/13,2.38%,IGF1R;ITGA6
prerank,actinin binding (GO:0042805),-0.2777101957621806,-0.8822475746712052,0.5902439024390244,0.8951127152390387,1.0,5/21,9.41%,CACNA1D;PDLIM5;CACNA1C;PROM1;RARA
prerank,N-acyltransferase activity (GO:0016410),0.3339139342272369,0.882064850654688,0.6356968215158925,1.0,1.0,5/32,12.73%,SIRT7;CERS2;GNPNAT1;NMT1;TLCD3B
prerank,ligand-gated ion channel activity (GO:0015276),0.343869546013931,0.8820291000007823,0.6508515815085159,1.0,1.0,5/30,14.09%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2846251270642931,0.882001500274914,0.853,1.0,1.0,93/431,19.61%,ARL4C;STK36;GNL3;ATL1;GBP3;PIP4K2B;HSP90AA1;GALK1;RAC1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;DRG2;TUBB2A;ABL1;CARS1;SARS2;GBP7;STK11;N4BP2;RRAGA;BRSK2;TARS1;RAP2A;RHOD;ATP1A2;AARS1;TUBD1;SIK1;TUBA1A;DHX36;DRG1;RAB10;ARL5B;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;DYNC1LI1;TLK1;ENPP1;ABCF2;HARS1;RAB13;PRKCI;DAPK1;AK6;TUBA1B;BMS1;GBP6;TUBB;RAB31;PPP5C;ACVR1B;ABCD2;RAB8A;SYN2;MTG2;RIT2;MLKL;OAS2;RAB21;OXSR1;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;RABL6;MTPAP;CDK11B
prerank,SH3 domain binding (GO:0017124),-0.2120936336770564,-0.8819696800426594,0.7317073170731707,0.8887106998408356,1.0,12/62,12.24%,WASF2;CD2AP;DAB2IP;REPS1;SOCS7;AFAP1L2;SGIP1;PLSCR1;ABI2;ADAM15;VASP;SHANK3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.27020781059625515,-0.8815549004675269,0.7015706806282722,0.8826290688620975,1.0,8/25,23.25%,PLEK;ZFYVE1;DAPP1;HIP1;ARAP3;KIF16B;AKT1;FCHSD2
prerank,ligand-gated channel activity (GO:0022834),0.34560970672291486,0.881462820650702,0.6523867809057528,1.0,1.0,5/29,14.09%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,bHLH transcription factor binding (GO:0043425),-0.29729693811464764,-0.8792349381725907,0.6666666666666666,0.8812585167239174,1.0,6/19,11.70%,TCF12;SIRT1;MAP3K10;LMO2;USF2;PSMD9
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.25852226404566403,-0.8772281238660437,0.6910112359550562,0.8789716071433926,1.0,8/28,21.63%,GABRG2;GABRA5;CHRNA7;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,nuclear receptor binding (GO:0016922),0.2960360294947126,0.876405652314508,0.7153284671532847,1.0,1.0,35/111,22.79%,WBP2;MED24;SMARCD3;MED12;MED14;WIPI1;TCF7L2;MED13;TACC1;TGFB1I1;GAS2L1;MED4;PRPF6;YWHAH;BRD8;JUP;PARK7;TADA3;MMS19;DDX5;SNW1;TRIP4;DAXX;THRAP3;NSD1;NCOR2;PRMT2;NCOA3;TRIP12;SMAD3;TAF1;GTF2B;PKN1;MED17;NCOA1
prerank,transferrin receptor binding (GO:1990459),-0.35900397382269833,-0.8759277602679121,0.6326530612244898,0.8751032751776897,1.0,3/10,10.78%,IKBKB;SNX2;IKBKG
prerank,transmitter-gated ion channel activity (GO:0022824),-0.2581513809443369,-0.8732247615700902,0.6703910614525139,0.8745848829663058,1.0,11/29,22.71%,GABRB1;GABRG2;GABRA5;GLRA2;GABRA4;GRIK3;GRIN2D;GABRG1;GABRA1;GRIK4;GLRA3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4153494745724231,0.8708435766826431,0.6336779911373708,1.0,1.0,2/11,10.86%,RDH11;AKR1B10
prerank,single-stranded telomeric DNA binding (GO:0043047),0.40618122796684497,0.8702392140310741,0.654357459379616,1.0,1.0,5/11,18.57%,HNRNPA2B1;RAD50;TERF1;NABP2;TERF2IP
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2582499585750574,-0.8702025411312942,0.6994535519125683,0.8744259382875882,1.0,11/27,32.09%,SLC9A2;SLC3A2;SLC8B1;SLC9B2;SLC4A8;SLC9A8;KCNK1;CNNM4;SLC8A1;SLC9A5;SLC8A2
prerank,GTP binding (GO:0005525),0.2826223216726065,0.8687227055328951,0.7573306370070778,1.0,1.0,35/172,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;TUBD1;TUBA1A;DRG1;RAB10;ARL5B;RHOBTB3;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,pyrophosphatase activity (GO:0016462),0.3162370896966204,0.8679744076486242,0.6892341842397336,1.0,1.0,12/50,18.33%,DDX3X;ENTPD7;PPA2;PRUNE1;NUDT3;BNIP2;ENPP1;PLPP4;PLPP5;NUDT16L1;DHX29;ATCAY
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3001152264054648,0.8658687732053956,0.6964477933261571,1.0,1.0,12/71,13.92%,DUSP18;ACP1;PTPRN;DUSP26;CDC14B;CDC25A;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2
prerank,tRNA binding (GO:0000049),-0.22571751117018746,-0.864412474980713,0.7857142857142857,0.8802225085496292,1.0,15/43,18.56%,EIF2AK4;EIF2A;XPOT;MRPS27;NSUN6;TRNAU1AP;AIMP1;DARS2;EEF1A1;TRNT1;TYW5;NAT10;ELP5;DALRD3;TRMT10B
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4185189432911192,0.8642301299486412,0.6365007541478129,1.0,1.0,2/10,14.64%,DPP9;DPP10
prerank,galactosyltransferase activity (GO:0008378),0.4077455731715518,0.8639515047629147,0.6315028901734104,1.0,1.0,2/11,12.71%,A4GALT;B4GALT5
prerank,telomerase RNA binding (GO:0070034),0.35233187783600395,0.8616636873257563,0.6662387676508345,1.0,1.0,6/22,20.48%,NHP2;WRAP53;DHX36;XRN1;SMG7;HNRNPU
prerank,MHC class I protein binding (GO:0042288),-0.3335207108167775,-0.861627565111063,0.6550632911392406,0.879741746009036,1.0,6/13,29.56%,TAPBP;TAP2;ATP5F1B;ABCB9;TAP1;TUBB4B
prerank,voltage-gated chloride channel activity (GO:0005247),0.41276217905319523,0.8615443944172568,0.6506746626686657,1.0,1.0,2/10,8.19%,CLCN2;CLCN4
prerank,motor activity (GO:0003774),-0.2134317797461831,-0.861444011545122,0.7473684210526316,0.8737276520740781,1.0,23/60,31.84%,KIF13B;KIF26B;MYL6;KLC1;KIF1C;KIF13A;MYO6;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23
prerank,kinase binding (GO:0019900),0.2791053209555434,0.8607655361706366,0.886,1.0,1.0,86/434,17.12%,CDKN2D;TNNI3;UBQLN1;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;RAC1;STUB1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;IL31RA;NEFH;SNAI1;NEK9;FBXO7;CARD16;TCF7L2;ERRFI1;DLG3;SQSTM1;THY1;FBXO5;BARD1;ARHGEF7;DVL1;RHOD;RFFL;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;GPRC5B;PER1;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;CNOT9;IQGAP1;PARK7;NPM1;HNRNPA0;LRRC14;ADD2;SUFU;VDAC1;TNS2;PTPN22;EMP2;PARP16;HTT;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;DLG2;SPRY2;OXSR1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4064906785342865,0.8606812356915954,0.6489675516224189,1.0,1.0,5/10,19.44%,EHMT2;SUV39H1;EHMT1;ASH1L;SETD5
prerank,guanyl ribonucleotide binding (GO:0032561),0.2796488225885602,0.8604485429004348,0.7798994974874371,1.0,1.0,40/196,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;RAB12;TUBD1;TUBA1A;RAB5B;DRG1;RAB10;ARL5B;RHOBTB3;RAB3B;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;PDE10A;RAB8B;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,single-stranded DNA binding (GO:0003697),0.2936765814542207,0.8587821042987126,0.7332635983263598,1.0,1.0,25/93,20.54%,APTX;RNF138;FUBP1;FBH1;MLH1;TDP1;RTF1;DHX36;TOP1;RBMS1;PARK7;TDP2;PMS2;MAPT;NUCKS1;SSBP2;HSPD1;NABP2;TOP3A;PCBP2;HMCES;RBBP8;NUP35;HNRNPU;SUB1
prerank,protein serine/threonine kinase activity (GO:0004674),0.279700776526624,0.8582142416875401,0.845,1.0,1.0,85/334,21.36%,MAPK9;CAMK2B;CAMK1G;STK36;ARAF;PDPK1;CSNK2A2;MAP3K14;EIF2AK3;DMPK;CDKL5;CASK;HUNK;TAOK1;HTATIP2;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;BRD4;NUAK1;SQSTM1;PAK3;STK11;BRSK2;KALRN;SBK1;SIK1;CIT;FAM20C;NRBP2;WNK2;TOP1;BRSK1;GRK3;MAPK6;CAMK2D;TLK1;CAMK2G;ATR;RPS6KA3;PRKCI;DAPK1;CSNK1D;NEK3;NRBP1;ROCK2;GRK2;CSNK1A1;ACVR1B;RPS6KA1;TRIO;CHEK2;MAP3K1;MAPK4;CAMK1D;TP53RK;CLK4;CDK7;OXSR1;ILK;PRKD2;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;PTK2B;MAPKAPK2;PAK5;ACVR2A;SGK3;MAP4K4;STK35;SMG1
prerank,CoA hydrolase activity (GO:0016289),0.368041204291889,0.858028431702067,0.6435374149659864,1.0,1.0,2/16,5.66%,ACOT9;ACOT11
prerank,beta-tubulin binding (GO:0048487),0.3328397667949418,0.856260131405391,0.6674907292954264,1.0,1.0,12/31,23.60%,TAOK1;GJB6;HTT;VAPB;TBCD;PACRG;ARL8B;PDCD5;DLEC1;FGF13;TTLL7;EML4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.27898190577155546,0.8558471178364534,0.7857142857142857,1.0,1.0,47/188,22.16%,ZBTB48;NFKB1;ZNF568;CREBZF;GLIS2;PSPC1;MTERF3;TCF7L2;IRF1;TBP;HDAC5;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;CALCOCO1;ZBTB20;SUV39H1;YY1;SOX6;HNRNPL;SMAD6;SOX5;KMT2D;RFX3;FOXC2;SOX13;TCF7;GABPB1;GABPB2;TBL1XR1;NONO;SOX4;KLF4;CARM1;GABPA;CTCF;TAF2;CREB3L2;HMGB1;ZBED4;SMAD3;ERBB4
prerank,sterol transfer activity (GO:0120015),-0.2829766127790292,-0.8557420934564045,0.6717557251908397,0.8800952889089138,1.0,3/17,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,Hsp70 protein binding (GO:0030544),0.3328047875748995,0.8544272845612456,0.6881851400730816,1.0,1.0,9/31,23.86%,IQCG;STUB1;GPR37;DNAJC10;PACRG;RPS3;DNAJC2;DNAJB12;TSC1
prerank,Hsp90 protein binding (GO:0051879),0.3318186010569988,0.8538772617499137,0.678743961352657,1.0,1.0,12/33,21.94%,UNC45A;TSC2;STUB1;STIP1;USP19;MAPT;PPP5C;CHORDC1;PACRG;RPS3;NPAS2;TELO2
prerank,actin monomer binding (GO:0003785),0.34308364356795584,0.8512819523830184,0.6618985695708712,1.0,1.0,3/22,6.07%,ABITRAM;MRTFA;ABL1
prerank,histone methyltransferase binding (GO:1990226),0.40178258775610576,0.8476540008463211,0.6514032496307238,1.0,1.0,2/11,6.32%,NOP56;PHF1
prerank,manganese ion binding (GO:0030145),0.30998370247783164,0.8473587231930669,0.705685618729097,1.0,1.0,12/48,21.34%,XPNPEP3;GALNT4;ABL1;POMGNT1;FAM20C;SOD2;TDP2;PPM1M;MTPAP;IMPA1;EXD2;ME1
prerank,phosphotyrosine residue binding (GO:0001784),0.3184830304075467,0.8471963165937156,0.6869047619047619,1.0,1.0,7/37,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.27661177562717,0.8469916904081968,0.8348348348348348,1.0,1.0,35/254,12.60%,HSF2;SP7;NFKB1;SMARCD3;MLXIP;NKX2-2;GLIS2;STAT6;TFDP1;NFKB2;RFX5;TCF4;TFCP2;IRF1;ZIC3;CASZ1;DBP;SOX9;SMARCD1;DDIT3;MDM4;ATMIN;SOX11;PRRX1;NKRF;ATF2;ZNF445;RBPJ;RFX4;NFAT5;IRF3;YY1;E2F3;CEBPG;CREB3
prerank,phospholipid transfer activity (GO:0120014),-0.2706274235288555,-0.8463777779231112,0.6724137931034483,0.8930811019433575,1.0,4/21,5.50%,OSBPL2;PITPNA;CERT1;PITPNC1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.2942626689828526,-0.844244865007577,0.6847826086956522,0.8907504545092136,1.0,4/16,22.44%,SCARB1;THBS1;SCARF1;STAB1
prerank,neurexin family protein binding (GO:0042043),0.4040596508207269,0.8442316096161224,0.6746626686656672,1.0,1.0,3/10,19.83%,NLGN3;NLGN2;SYTL2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.24827609072601936,-0.8416175434617944,0.7395833333333334,0.889939396747019,1.0,7/26,17.61%,PPME1;PPP1R1A;ENSA;PPP1R14C;LMTK2;PPP1R8;BOD1L1
prerank,lysophospholipase activity (GO:0004622),0.3505305983494423,0.8413220484343576,0.6851119894598156,1.0,1.0,6/20,20.14%,LYPLAL1;GDPD3;ENPP2;PNPLA7;GDE1;ABHD16A
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.38597702592429883,0.8400453040117069,0.6837606837606838,1.0,1.0,12/12,61.43%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW3;OPN1MW;RRH;GPR52;GPR88;OPN3
prerank,general transcription initiation factor binding (GO:0140296),-0.258817262011343,-0.8387943664803849,0.7044334975369458,0.8897424149951628,1.0,11/25,23.64%,THRA;AR;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,lysine N-methyltransferase activity (GO:0016278),0.3451116395883727,0.8366599425661888,0.6868421052631579,1.0,1.0,5/20,15.49%,ETFBKMT;SETD7;EHMT2;EHMT1;ATPSCKMT
prerank,histone demethylase activity (GO:0032452),0.3304021387894137,0.8366531419088707,0.698870765370138,1.0,1.0,7/27,19.43%,KDM4D;KDM7A;JARID2;KDM2B;KDM6B;KDM3B;KDM6A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.28746795294960903,0.8362961098664612,0.7710084033613446,1.0,1.0,27/91,23.33%,GSDMD;RPH3A;WIPI1;TIRAP;SNX14;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;MAPT;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;KCNH1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18;WIPI2;SYT7;SH3PXD2B
prerank,cAMP binding (GO:0030552),0.3957926773410236,0.8360861143562051,0.6992592592592592,1.0,1.0,3/11,15.76%,PDE4A;PDE10A;PDE4B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2777255642317208,0.8339415269850596,0.8169868554095046,1.0,1.0,34/147,16.51%,SH3BP5;NUCB2;ARHGEF10;GAPVD1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;KALRN;MYCBP2;DOCK8;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;VAV2;DENND4C;DENND5A;RIC8B;ALS2;MON1A;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;EEF1B2;CYTH1;FARP2;DNMBP;ARHGEF6;EPS8L1;DENND6A
prerank,protein tyrosine kinase binding (GO:1990782),0.28952049487215764,0.8328703370592474,0.7473233404710921,1.0,1.0,12/71,14.97%,HSP90AA1;SQSTM1;SIRPA;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,"DNA binding, bending (GO:0008301)",0.372187315517548,0.8322032989938866,0.6927453769559033,1.0,1.0,5/14,22.00%,HMGB3;SAP30L;TERF1;FOXD1;HMGB1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38883928035137927,0.8298135216413669,0.6870554765291608,1.0,1.0,2/11,4.91%,RPH3A;ITPR1
prerank,DNA polymerase binding (GO:0070182),-0.27006411931332464,-0.8261464141635276,0.7136929460580913,0.9086635219906083,1.0,9/18,26.42%,PTGES3;HSP90AB1;NAT10;SMG6;RTEL1;FANCI;CDK2AP1;POLG2;PCNA
prerank,SH2 domain binding (GO:0042169),0.3156755019854146,0.8236996321042844,0.7376654632972323,1.0,1.0,12/31,24.20%,ABL1;SQSTM1;DAG1;RACK1;BLNK;RUFY1;AFAP1;CCDC88A;DLC1;SH3PXD2B;KHDRBS1;JAK2
prerank,ligand-gated cation channel activity (GO:0099094),0.28741560113602405,0.8236449709328209,0.7601279317697228,1.0,1.0,7/75,14.09%,ASIC1;GRIN1;GRIK5;KCNJ10;GRIN2A;GRIA1;GRIA2
prerank,adenylyltransferase activity (GO:0070566),0.3432092085756894,0.8222925894721664,0.714095744680851,1.0,1.0,10/21,26.90%,ABL1;FLAD1;COASY;OAS2;MTPAP;SELENOO;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,protein kinase binding (GO:0019901),0.26664293317933013,0.8217923614464075,0.936,1.0,1.0,92/479,18.28%,CDKN2D;TNNI3;DACT2;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;HSP90AA1;RAC1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;PICK1;NELL1;TIRAP;IL31RA;NEFH;NEK9;FBXO7;TCF7L2;ERRFI1;ABL1;SQSTM1;THY1;FBXO5;ARHGEF7;DVL1;RHOD;RFFL;HDAC5;SIRPA;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;SOX9;GPRC5B;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;YWHAG;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;IQGAP1;NPM1;MAPK8IP3;HNRNPA0;ADD2;RACK1;ROR2;SUFU;VDAC1;EMP2;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;TCF3;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;SPRY2;OXSR1;TNIP1;CAMK2N1;ILK;PRKD2;RELB;CCDC88A;PRKAR1A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.29645966481319874,0.8193503164053227,0.7323628219484882,1.0,1.0,8/48,18.02%,NALCN;MMGT1;CALHM2;SLC39A1;TRPM3;SLC41A1;ATP6V1B2;PKD2
prerank,ion gated channel activity (GO:0022839),0.3322834571461728,0.8191433021116229,0.7016434892541087,1.0,1.0,4/24,12.53%,TMEM63A;KCNT2;TMEM63C;TTYH2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.28258748777869086,0.8149759814103474,0.7790821771611526,1.0,1.0,20/72,22.30%,GSDMD;RPH3A;TIRAP;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18
prerank,endopeptidase regulator activity (GO:0061135),0.30598936493706275,0.8149255681261467,0.7432905484247374,1.0,1.0,5/40,12.12%,USP14;ABCA2;RENBP;PSME2;TFPI
prerank,sodium channel activity (GO:0005272),0.3089500143647663,0.8148496994735018,0.7552693208430913,1.0,1.0,4/37,10.99%,ASIC1;SCN7A;GRIK5;SCN1A
prerank,glycine binding (GO:0016594),0.3913359157179677,0.811607399402283,0.7122302158273381,1.0,1.0,2/11,14.46%,GRIN1;GLRA1
prerank,snoRNA binding (GO:0030515),0.31252504757282856,0.8114134362026024,0.7236679058240396,1.0,1.0,2/30,3.94%,NHP2;NOP56
prerank,peptidoglycan binding (GO:0042834),-0.3286776139307661,-0.8113570287782607,0.7412790697674418,0.9297850936727001,1.0,2/10,4.72%,HK1;NOD1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2877027962567786,0.8112643176827984,0.7592997811816192,1.0,1.0,21/60,24.09%,PPM1B;CDC14B;PPP1CC;PPM1H;CTDSPL2;CAMK2G;PPM1E;CTDSP2;PPP5C;PPM1M;PPP2CB;TAB1;PHLPP2;PPP4C;PPM1A;LRRK1;PPM1F;RPAP2;PTEN;PPP3CB;PPM1D
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.26420423962007444,-0.8073047394474809,0.7171314741035857,0.930865553284419,1.0,7/19,21.63%,GABRG2;GABRA5;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,telomeric DNA binding (GO:0042162),0.3105219214118579,0.8064757028078006,0.7323420074349443,1.0,1.0,11/32,21.94%,ZBTB48;XRCC6;HNRNPD;HNRNPA2B1;RAD50;TERF1;UPF2;SMG7;TERF2IP;SMG1;TELO2
prerank,DNA secondary structure binding (GO:0000217),0.31417434608174516,0.8058188404893067,0.7375455650060754,1.0,1.0,10/31,22.00%,XRCC2;HMGB3;ABL1;FANCM;YY1;MAPT;RBBP8;KMT2A;RAD18;HMGB1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.33041677282602544,-0.8053299627513104,0.6833855799373041,0.9281170440830419,1.0,4/10,13.99%,SETD2;NSD2;SETD3;SMYD2
prerank,chemoattractant activity (GO:0042056),0.32058349214212783,0.805055324598887,0.7487562189054726,1.0,1.0,3/26,10.19%,NTF3;FGF10;GDNF
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.31643662190746513,0.8039569396714343,0.7481108312342569,1.0,1.0,8/30,18.90%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5;SLC25A37;SLC11A2
prerank,peptidase inhibitor activity (GO:0030414),0.30622038695004555,0.8030425869031419,0.7563025210084033,1.0,1.0,6/33,19.59%,USP14;RENBP;TFPI;SERPIND1;TIMP2;PROS1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2978869457893017,0.8006485803101209,0.7552693208430913,1.0,1.0,7/42,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,endonuclease activity (GO:0004519),0.28800632094817835,0.7986201440184371,0.7779030439684329,1.0,1.0,10/49,17.10%,NTHL1;APLF;LACTB2;N4BP2;RCL1;CPSF3;AGO3;SND1;MRE11;ZC3H12C
prerank,3'-5' DNA helicase activity (GO:0043138),0.34691014805917175,0.7985842903101632,0.7352941176470589,1.0,1.0,3/16,11.55%,HELQ;FBH1;FANCM
prerank,solute:anion antiporter activity (GO:0140323),0.3593862917161532,0.7947438976888161,0.7343324250681199,1.0,1.0,1/14,1.47%,SLC7A11
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2995213223527002,0.7935521894198074,0.7544696066746126,1.0,1.0,8/34,15.49%,ETFBKMT;SETD7;EZH2;EHMT2;NSD3;SUV39H1;EHMT1;ATPSCKMT
prerank,phosphatidylinositol binding (GO:0035091),0.27010118504274755,0.7908374592959951,0.8361344537815126,1.0,1.0,21/91,18.25%,PLEKHN1;RPH3A;SNX5;ITPR1;PIGU;THY1;SNX10;SNX24;SNX11;PIGK;MAPT;TULP3;NUMA1;SNAP91;DPEP1;PARD3B;SNX4;PITPNM2;PHF12;CCDC88A;ZFYVE16
prerank,double-stranded DNA binding (GO:0003690),0.25467819476633363,0.7896669284499036,0.977,1.0,1.0,98/531,22.00%,CAMTA2;HSF2;POU6F1;ZNF23;APTX;ZBTB48;HMGB3;PKNOX2;NTHL1;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;RFX5;SNAI1;TCF4;TFCP2;FBH1;ZNF276;ABL1;TDP1;ZIC3;ARNT;ZBTB7B;TEAD1;ZNF32;DBP;SOX9;XRCC6;KIN;LIN28B;PSIP1;HOXB8;ATF2;TOP1;ZBTB20;ZNF445;GLIS1;RFX4;BACH2;NFAT5;IRF3;RBMS1;YY1;E2F3;NFIX;PARK7;CEBPG;CREB3;CREB3L4;FOXJ3;MAPT;ESRRG;CAMTA1;BCL6;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;HOXC8;CLOCK;RAD50;TERF1;MBD1;OSR1;TCF7;MEIS2;ZNF177;RBBP8;MECP2;CUX1;BCL11B;KLF13;SOX4;ZIC4;RPS3;KLF4;GABPA;PKNOX1;HNRNPU;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;NPAS2;SMAD2;ETV3;MSH3;HMGB1
prerank,tau-protein kinase activity (GO:0050321),0.32709521269787795,0.789552368974305,0.7349081364829396,1.0,1.0,5/20,14.18%,TAOK1;CDK5;BRSK2;BRSK1;ROCK2
prerank,antiporter activity (GO:0015297),0.33000358813505165,0.7880904355779049,0.751358695652174,1.0,1.0,3/20,8.19%,SLC35D2;ATP1A3;CLCN4
prerank,microtubule motor activity (GO:0003777),-0.2018345737626785,-0.7868276863333853,0.8536585365853658,0.9545558282431161,1.0,27/51,38.89%,KIF13B;KIF26B;KIF1C;KIF13A;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23;KIF11;KIF1B;KIF15;KIF21B;KIF17;CENPE;DNAH3
prerank,DNA-binding transcription factor binding (GO:0140297),0.2594167914176222,0.7847156491316374,0.8974874371859296,1.0,1.0,47/189,22.40%,TEAD3;DUSP26;BBS10;CRTC1;USF1;MIER2;TCF7L2;BBS7;TBP;HDAC5;SIK1;DDIT3;CRTC3;TTC8;HDAC4;TWIST1;PRRX1;RBL2;ATF2;PSMC5;RBPJ;BCL2;MTA2;PARK7;NPM1;HDAC1;RUNX1T1;PIAS3;TCF3;CTBP1;CBX5;MTDH;TLE5;RBBP8;ATN1;KLF4;GABPA;PIAS1;MIER1;SMAD2;TCERG1;HMGB1;SMAD3;MTA1;TAF1;IFI27;ID2
prerank,glutamate receptor binding (GO:0035254),0.33706144322385884,0.7831532797927241,0.7496671105193076,1.0,1.0,5/17,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,sequence-specific DNA binding (GO:0043565),0.25201182527090055,0.7829824809047908,0.99,1.0,1.0,112/590,22.21%,MMP12;HSF2;POU6F1;ZNF23;MYRF;PKNOX2;ZEB2;USF1;NR2F2;TEF;MAFG;GLIS2;NR1D2;XBP1;RORA;KMT2B;NFKB2;POU2F1;RFX5;SNAI1;SLTM;TCF4;TCF7L2;TFCP2;ZNF276;ABL1;ZNF35;ZIC3;ARNT;ZBTB7B;ZNF711;TEAD1;ZNF32;ZBTB38;DBP;SOX9;XRCC6;HNRNPD;PRMT5;HDAC4;LIN28B;CALCOCO1;HOXB8;ATF2;ZBTB20;KDM2B;RBPJ;GLIS1;RFX4;BCL2;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;CEBPG;CREB3;CREB3L4;PRMT1;CBFB;FOXJ3;MAPT;ESRRG;BCL6;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;SAFB2;HOXC8;CLOCK;TERF1;UPF2;MBD1;SOX13;OSR1;TCF7;MEIS2;ZNF177;SMG7;MECP2;CUX1;KMT2A;BCL11B;TERF2IP;FOXD1;KLF13;SOX4;ZIC4;TET1;KLF4;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;SMG1;NPAS2;FOXO1;ETV3;TELO2;SMAD3;TAF1;HOXA7
prerank,glutamate receptor activity (GO:0008066),-0.25738184146251597,-0.7803406844851091,0.776,0.9596873026623669,1.0,3/19,4.76%,GRM7;GRM1;GRM3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.29699468347831676,-0.7788407238258411,0.739413680781759,0.955818493169214,1.0,5/12,19.85%,NUDT5;ENTPD1;ENTPD6;SLC25A42;CANT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.33008797557725955,0.7766127907641377,0.7470355731225297,1.0,1.0,5/17,21.40%,AK4;AK5;AK3;CMPK1;AK1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2986330017159383,0.7757864260042159,0.8054892601431981,1.0,1.0,14/33,24.49%,AUP1;PARK7;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5;RPS3;TCERG1;UBA2;SIAH2;TRAF6
prerank,RNA polymerase binding (GO:0070063),0.33230232326115516,0.7743597364688681,0.7837465564738292,1.0,1.0,6/18,21.95%,BIN1;PPIB;CCNT1;YTHDC2;CCNT2;TCERG1
prerank,Notch binding (GO:0005112),0.3138974167851876,0.7739098952986896,0.7916120576671035,1.0,1.0,5/22,18.65%,TCIM;SNW1;JAG1;SNED1;NCOR2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30363079149114036,0.7694357096830166,0.7920792079207921,1.0,1.0,8/27,17.91%,AUP1;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2716908483409723,0.7678471316039189,0.8044444444444444,1.0,1.0,7/57,9.77%,UQCRC1;NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,insulin-like growth factor binding (GO:0005520),-0.26522631448416345,-0.7675965292303359,0.7927272727272727,0.9677523375111104,1.0,2/15,2.38%,IGF1R;ITGA6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3101291317308509,-0.7650295134725568,0.7674418604651163,0.9655487045155157,1.0,5/10,20.77%,STAMBPL1;CYLD;STAMBP;OTUD4;OTUD5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.30024933029042833,-0.7630915639990257,0.7699115044247787,0.9621175060117272,1.0,4/11,9.09%,UBE2K;RBX1;AMFR;UBOX5
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.244878558625867,0.7608538130164543,0.992,1.0,1.0,113/597,22.21%,HSF2;POU6F1;ZNF23;ZBTB48;NFKB1;ZNF568;PKNOX2;CREBZF;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;PSPC1;RFX5;SNAI1;MTERF3;TCF4;TCF7L2;TFCP2;ZNF276;IRF1;TBP;ABL1;ZIC3;ARNT;ZBTB7B;DHX33;TEAD1;HDAC5;ZNF32;DBP;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;LIN28B;SOX11;CALCOCO1;HOXB8;ATF2;ZBTB20;GLIS1;RFX4;SUV39H1;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;SOX6;CEBPG;CREB3;CREB3L4;HNRNPL;CENPC;FOXJ3;ESRRG;BCL6;SMAD6;SOX5;KMT2D;RFX3;NR2C2;TCF7L1;FOXC2;HSPD1;MAF;HOXC8;CLOCK;SOX13;OSR1;TCF7;GABPB1;GABPB2;MEIS2;TBL1XR1;ZNF177;CUX1;BCL11B;NONO;KLF13;SOX4;ZIC4;ZW10;KLF4;CARM1;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;TAF2;NFATC3;CREB3L2;FOXJ2;GLI3;NPAS2;ETV3;HMGB1;ZBED4;SMAD3;ERBB4;HOXA7
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.33868603050377855,0.760317258454364,0.772005772005772,1.0,1.0,3/14,19.24%,SPOCK1;SPOCK2;TIMP2
prerank,WW domain binding (GO:0050699),0.2992646838656784,0.7602972997244027,0.8020176544766708,1.0,1.0,2/26,4.74%,TCEAL5;PMEPA1
prerank,carboxypeptidase activity (GO:0004180),0.28841168600327227,0.7594982981672199,0.8231046931407943,1.0,1.0,6/35,16.08%,CPXM1;AGBL3;PEPD;CPXM2;CTSZ;AGBL4
prerank,R-SMAD binding (GO:0070412),0.3166390007026422,0.7569132241089072,0.7876344086021505,1.0,1.0,8/18,22.12%,PMEPA1;SMAD6;DDX5;SMURF1;RANBP3;PPM1A;SMAD2;SMAD3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.27862423148185017,0.7564168009537551,0.7962529274004684,1.0,1.0,14/44,19.64%,KMT2B;SETD7;EZH2;EHMT2;SETD1A;NSD3;SUV39H1;EHMT1;KMT2D;ASH1L;NSD1;KMT2A;SETD5;KMT5B
prerank,nuclear import signal receptor activity (GO:0061608),0.3357543543828445,0.7563309001225481,0.7700680272108843,1.0,1.0,4/15,18.70%,KPNA3;KPNB1;TNPO1;KPNA1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.36653156023983396,0.7562664585608702,0.7711738484398217,1.0,1.0,2/10,10.31%,CACNB4;CACNB1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3359652919099039,0.7559681366735823,0.7783783783783784,1.0,1.0,4/14,21.40%,AK4;AK5;CMPK1;AK1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2572465593714007,0.7547554419206942,0.8596858638743455,1.0,1.0,15/100,13.92%,GSDMD;PLEKHN1;RPH3A;WIPI1;OGT;MYO1B;PLEKHA3;SNX24;ATG2A;SAP30L;ADAP2;IQGAP1;ARAP1;SNX11;MAPT
prerank,calcium-activated potassium channel activity (GO:0015269),0.35992282229983663,0.751565899926738,0.76,1.0,1.0,1/11,6.83%,KCNMA1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.34522332292158375,0.746858180808863,0.7743813682678311,1.0,1.0,3/11,17.75%,PPP1R2;PPP1R14A;PPP1R11
prerank,serotonin receptor activity (GO:0099589),-0.2419152098845463,-0.7445569467530218,0.8642533936651584,0.9705571508047234,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2419152098845463,-0.7445569467530218,0.8642533936651584,0.9705571508047234,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2419152098845463,-0.7445569467530218,0.8642533936651584,0.9705571508047234,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,myosin V binding (GO:0031489),0.3286645781514473,0.7431582679807575,0.8032564450474898,1.0,1.0,6/15,25.36%,RAB10;RAB3B;RAB8A;RAB6A;RAB11B;RAB11A
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.31427660850327066,0.7420749277162648,0.8062330623306233,1.0,1.0,4/17,15.15%,BLVRB;BLVRA;MECR;DPYD
prerank,gap junction channel activity (GO:0005243),0.3040005347591732,0.7414052938505914,0.8120805369127517,1.0,1.0,2/22,9.65%,GJB2;GJB6
prerank,wide pore channel activity (GO:0022829),0.3010006886589134,0.740947971317094,0.8144736842105263,1.0,1.0,2/23,9.65%,GJB2;GJB6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34069469333342933,0.7389152429530006,0.7997159090909091,1.0,1.0,6/12,24.61%,PIK3CB;PIK3C2B;PIK3C3;IPMK;ATM;PIK3C2A
prerank,tropomyosin binding (GO:0005523),-0.24623898626534732,-0.7380398669768146,0.8404669260700389,0.9735499904861801,1.0,7/16,40.81%,NEBL;TMOD1;LMOD1;CALD1;TNNT3;S100A6;PYCARD
prerank,tRNA methyltransferase activity (GO:0008175),0.3220971096977027,0.7373103204956071,0.8108108108108109,1.0,1.0,3/16,12.90%,TRDMT1;METTL2A;METTL2B
prerank,heme binding (GO:0020037),0.2579063598806173,0.7370698347650483,0.8762322015334063,1.0,1.0,8/65,14.59%,DGCR8;CYP27A1;RSAD1;BACH1;CYP26B1;CYP51A1;PTGS2;PXDN
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.29966465889175087,0.7357466038040055,0.829923273657289,1.0,1.0,2/23,5.17%,WIPI1;SNX14
prerank,regulatory RNA binding (GO:0061980),0.2723857610764889,0.7342280808833045,0.8486997635933806,1.0,1.0,10/38,22.97%,TARBP2;ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,protein phosphatase binding (GO:0019903),0.2464293124958773,0.7338429715518936,0.8903688524590164,1.0,1.0,32/117,22.67%,EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;SIRPA;PPP1R9B;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;RACK1;ANAPC4;PPP1R16A;MAPT;STX17;MTMR4;PPP1R11;JAK1;SMG7;ANAPC5;ARPP19;KIFAP3;IGBP1;ATP2B4;FOXO1;TRAF2;ITGA1;MAP2K7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3255467063056411,0.7320739688566164,0.7942779291553134,1.0,1.0,2/14,4.85%,ISCA2;RSAD1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2646447237691752,0.7306264949402513,0.8433179723502304,1.0,1.0,7/47,16.34%,SLC7A11;SLC22A4;SLC38A9;SLC7A2;SLC38A10;SLC1A5;SLC6A13
prerank,calcium-release channel activity (GO:0015278),0.3214176241670387,0.730615366994595,0.8221614227086184,1.0,1.0,4/17,18.02%,ITPR1;TPCN1;RASA3;PKD2
prerank,semaphorin receptor binding (GO:0030215),-0.2227661501875686,-0.7294702246631413,0.8793103448275862,0.9783927160858954,1.0,17/23,43.07%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;PLXNB1;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F;SH3BP1
prerank,DNA polymerase activity (GO:0034061),-0.22805497490269316,-0.7281324229180702,0.8893805309734514,0.9740842685805347,1.0,10/22,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;TERT;POLE2;POLQ;POLK;POLI
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3044771452723797,0.7275645390344405,0.8054421768707483,1.0,1.0,9/18,23.40%,USP15;TGFB1;SMAD6;TGFBR1;TGFBR3;SMAD7;SMAD2;SMAD3;FKBP1A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.3255456489262126,0.7274628121102922,0.8257790368271954,1.0,1.0,4/14,19.20%,USP7;USP15;USP9X;YOD1
prerank,SUMO binding (GO:0032183),-0.26962069337023403,-0.726564395048046,0.8548387096774194,0.9696740101369609,1.0,5/13,19.97%,CASP8AP2;PML;TDG;HABP4;CBX4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2833916579475746,0.7262032716199681,0.820125786163522,1.0,1.0,2/29,3.42%,ABHD10;GBA2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2146536587562436,-0.7254145018614607,0.888268156424581,0.9650553285606995,1.0,9/29,20.16%,SIRT1;NFATC1;NBR1;DUSP10;PTPRJ;ACE;MAPKAPK3;DUSP1;GCH1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.28947817090944766,0.7230041913694786,0.8456632653061225,1.0,1.0,2/24,6.60%,GSDMD;PLEKHA3
prerank,solute:proton symporter activity (GO:0015295),0.3152566220343777,0.7220937926548646,0.8047808764940239,1.0,1.0,1/16,0.83%,SLC17A5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2568086535985973,0.7216422652379683,0.8602860286028603,1.0,1.0,5/55,6.25%,SLC6A11;SLC22A4;SLC16A12;SLC38A9;SLC7A2
prerank,protein kinase regulator activity (GO:0019887),0.24387586834549804,0.7214530688796539,0.8986415882967607,0.9996328234511319,1.0,11/95,12.27%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;CCNC;MAPK8IP1;STK11;GPRC5B;SH3BP5L;CCNH;NPM1
prerank,anion channel activity (GO:0005253),0.25367585096546275,0.7195905929525472,0.8781284004352558,0.9996568938540329,1.0,9/61,14.46%,BEST1;LRRC8A;VDAC2;CLCN4;CLIC1;GABRB3;VDAC1;CLCN7;GLRA1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2643372091665396,-0.7173030090166934,0.8142857142857143,0.9695454753795544,1.0,3/13,8.34%,EZR;PRKAR2B;CSK
prerank,glucuronosyltransferase activity (GO:0015020),0.30261298910587736,0.7166988415329283,0.8243243243243243,1.0,1.0,1/19,3.69%,CHPF
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24757128526871544,0.7164787190626967,0.8847780126849895,0.9986397533438222,1.0,14/74,17.27%,XYLB;GALK1;DCAKD;PANK4;COASY;FAM20C;PIK3CB;IPPK;PI4KB;NT5C3A;CHKB;PIK3C2B;PIK3C3;IPMK
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3393844524295595,0.7148413016287672,0.8167388167388168,0.998327469136192,1.0,5/10,24.61%,PIK3CB;PIK3C2B;PIK3C3;ATM;PIK3C2A
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.21231567846855662,-0.7134966957063431,0.9090909090909091,0.9682766075867576,1.0,17/27,36.70%,POLR3B;TENT2;POLR3A;CRCP;MED20;POLR1F;POLR3H;TERT;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,death domain binding (GO:0070513),0.3341954505469966,0.7134022953993965,0.8020527859237536,0.9976083917877432,1.0,3/11,12.69%,BAX;BCL2;RACK1
prerank,store-operated calcium channel activity (GO:0015279),0.34456894421684,0.7090823233615167,0.8149300155520995,1.0,1.0,1/10,2.25%,ORAI2
prerank,methyl-CpG binding (GO:0008327),0.28984994982665213,0.7081730503751082,0.8371794871794872,0.9988416175968272,1.0,6/22,19.34%,ZBTB38;PRMT5;PRMT1;MBD1;MECP2;TET1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2782801330177874,0.70711120965148,0.8545454545454545,0.9978227151732786,1.0,5/27,14.06%,ITPR1;MMGT1;ATP2B1;KCNA1;SLC41A1
prerank,death receptor activity (GO:0005035),0.32925399457817667,0.7065614660806054,0.8270106221547799,0.9961645721683801,1.0,2/11,12.49%,EDA2R;TNFRSF25
prerank,phosphatidylinositol kinase activity (GO:0052742),0.31276634617245935,0.7054876696334622,0.8439226519337016,0.9950886919465217,1.0,8/15,25.26%,PIK3CB;PI4KB;PIK3C2B;PIK3C3;PIKFYVE;ATM;PIK3C2A;PI4KA
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.33339041618397575,0.7030105428029346,0.8284023668639053,0.995535699328931,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.24665538087933656,-0.7026901038954588,0.8711864406779661,0.9749212896704562,1.0,3/15,7.93%,SOCS7;PIK3R3;SOCS4
prerank,cation transmembrane transporter activity (GO:0008324),0.25767428620523347,0.7026129202732317,0.879862700228833,0.9937066490843564,1.0,7/48,14.36%,SLC38A9;SLC7A2;MMGT1;SLC39A1;SLC25A38;SLC41A1;SLC1A5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2294352075695694,0.6999682020740813,0.9626639757820383,0.994299577285786,1.0,32/173,21.02%,POU6F1;NFKB1;ZNF25;ZEB2;MXI1;SNAI1;ZNF692;ZEB1;MXD1;ZBTB5;CC2D1A;NFX1;ZBTB20;YY1;NACC2;BACH1;PEG3;TRPS1;BCL6;SATB1;TCF3;GTF2IRD1;ZFP37;SOX13;ZFP90;ZNF177;MITF;E2F6;CTCF;ZNF219;ZBTB32;NFATC3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.20682671203941969,-0.6954938844281894,0.9384615384615385,0.9767659705908106,1.0,17/27,36.70%,POLR3B;POLR3A;CRCP;PRIMPOL;MED20;POLR1F;POLR3H;PRIM1;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31626252453057113,0.6949890059317184,0.8607038123167156,0.9975641975772966,1.0,2/12,12.03%,ISCA2;CISD1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.2845070728114476,-0.6943500284546668,0.8354037267080745,0.9720713853061425,1.0,7/10,32.97%,DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,cholesterol binding (GO:0015485),0.2533122180591133,0.6942743632021103,0.888,0.996093914589085,1.0,13/47,22.05%,STARD5;ERLIN2;VDAC2;SOAT1;PTCH1;STARD3;VDAC1;SIDT1;SCARB2;OSBPL1A;NPC2;ABCG1;NPC1
prerank,N-acetyltransferase activity (GO:0008080),0.2876690786263096,0.6904674245958091,0.854521625163827,0.9977721430572903,1.0,2/19,6.77%,ATAT1;GNPNAT1
prerank,cAMP response element binding (GO:0035497),-0.27255701387227405,-0.6869923061680325,0.8680981595092024,0.9737391685349848,1.0,5/10,25.65%,E4F1;CREB1;JUN;CREB3L1;HMGA2
prerank,kinase activator activity (GO:0019209),-0.20319367851734638,-0.6869214496798376,0.9382022471910112,0.9679900876383838,1.0,3/30,2.43%,CAB39;STRADA;MARK2
prerank,MHC class II protein complex binding (GO:0023026),0.3164553996885025,0.6844758662351148,0.8505392912172574,1.0,1.0,1/11,2.67%,HSP90AA1
prerank,lipase activity (GO:0016298),0.2547545330724415,0.6831168866045805,0.9049773755656109,1.0,1.0,5/43,16.33%,LPL;SMPD2;PITPNM3;DDHD2;LDAH
prerank,transcription coactivator binding (GO:0001223),0.28211300869723455,0.6824964106510869,0.857916102841678,0.9991627470408324,1.0,3/20,8.25%,RORA;CDK9;CIT
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.26945924594878823,-0.6809446615677539,0.8476190476190476,0.9679791245665306,1.0,1/11,0.75%,DAB2IP
prerank,chloride channel activity (GO:0005254),0.24210319648803272,0.6805922829109815,0.9129488574537541,0.9989367988064564,1.0,8/59,14.46%,BEST1;CLCN2;CLCN4;CLIC1;GABRB3;TTYH2;CLCN7;GLRA1
prerank,PDZ domain binding (GO:0030165),0.23733722366629834,0.6761725254378607,0.9093886462882096,1.0,1.0,14/61,21.06%,SYNJ2;FZD3;SLC22A4;CIT;ATP2B1;TMEM88B;GRIA1;ARHGAP29;MAP2K2;NSF;PLEKHA1;TGFBR3;FZD2;ATP2B4
prerank,hydro-lyase activity (GO:0016836),0.24838240460154276,0.672153187367472,0.9248554913294798,1.0,1.0,7/41,14.75%,HADHB;HSD17B4;ENO2;CDYL;PARK7;EHHADH;ECHDC1
prerank,O-methyltransferase activity (GO:0008171),-0.2730616805005265,-0.6686409623729428,0.8878787878787879,0.9734503063645723,1.0,7/10,42.47%,COQ3;CMTR1;MEPCE;FTSJ3;ASMT;BCDIN3D;CMTR2
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.20981563539063844,-0.668406845158023,0.9517543859649122,0.9679429942758387,1.0,9/21,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;POLE2;POLQ;POLK;POLI
prerank,hormone receptor binding (GO:0051427),0.2973734982257245,0.6644068118890891,0.8676880222841226,1.0,1.0,1/14,3.71%,PTHLH
prerank,mannose binding (GO:0005537),0.3096416220813758,0.663505126856991,0.8624641833810889,1.0,1.0,1/12,8.24%,LMAN2L
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3206804242778597,0.6634153469036816,0.8841010401188707,1.0,1.0,2/11,17.73%,ITPR1;RASA3
prerank,ribonuclease P RNA binding (GO:0033204),-0.2650017437852891,-0.6626621917399377,0.8699690402476781,0.9674538091558125,1.0,6/10,37.57%,POP1;RPP14;RPP21;POP5;POP4;RPP38
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.23549958620515798,-0.6597394648805593,0.9180327868852459,0.9643167718335018,1.0,6/14,36.71%,KCNJ2;KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4
prerank,NAD+ binding (GO:0070403),0.30265318082582326,0.6561593947409854,0.890190336749634,1.0,1.0,3/12,15.96%,SIRT2;SIRT5;ZC3HAV1
prerank,ribonuclease P activity (GO:0004526),0.30555961602645126,0.6541228386020151,0.9048991354466859,1.0,1.0,2/11,13.55%,PRORP;RPP30
prerank,ATPase regulator activity (GO:0060590),0.2454852814770782,0.6495969579935708,0.9141835518474374,1.0,1.0,11/38,22.10%,BAG1;BRSK2;KATNB1;HSPH1;DNAJB6;DNAJC24;DNAJC10;BAG4;TOR1AIP2;ATP1B2;SIL1
prerank,endoribonuclease activity (GO:0004521),0.24816740897456774,0.6461782327941209,0.9199029126213593,1.0,1.0,7/32,17.10%,LACTB2;RCL1;ENDOV;CPSF3;AGO3;SND1;ZC3H12C
prerank,translation elongation factor activity (GO:0003746),-0.22631252318830114,-0.6460526688788469,0.928082191780822,0.9693098325717503,1.0,7/14,29.73%,EEF2;EEF1A1;GTPBP1;EIF5A;EIF5AL1;TSFM;EIF5A2
prerank,carboxylic acid binding (GO:0031406),-0.17191111026249087,-0.6458248499537623,0.9647887323943662,0.9639172820554369,1.0,12/38,29.67%,GRM7;UBR1;NOS3;PHYH;GLRA2;GLRB;SESN2;GLRA3;HIF1AN;NOS1;EPDR1;GLUD1
prerank,sodium:proton antiporter activity (GO:0015385),-0.2507218232108175,-0.6446157998153884,0.9039735099337748,0.9593588540954061,1.0,2/11,9.73%,SLC9A2;SLC9B2
prerank,NAD binding (GO:0051287),0.25390068578134883,0.6438999573466975,0.91875,1.0,1.0,5/26,16.05%,SIRT2;QDPR;SIRT5;ZC3HAV1;CTBP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.29041029650563727,0.6419784365148457,0.8953168044077136,1.0,1.0,3/14,12.01%,NUDT12;NUDT3;ENPP1
prerank,single-stranded DNA helicase activity (GO:0017116),0.2717605283376498,0.6418714723923445,0.9036939313984169,1.0,1.0,1/19,2.77%,HELQ
prerank,amino acid binding (GO:0016597),0.25016957436665177,0.6411089779764136,0.9193742478941035,1.0,1.0,5/31,18.27%,GRIN1;AARS1;GCLC;GLRA1;ASS1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.28296679370429934,0.6408564369978249,0.8829201101928374,1.0,1.0,6/15,26.38%,SLC1A3;SLC1A5;SLC1A2;SLC38A7;SLC25A12;SLC17A6
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.28363704565684444,0.6404272752750938,0.9050131926121372,1.0,1.0,1/16,2.63%,NTHL1
prerank,endopeptidase activator activity (GO:0061133),-0.25932593126093545,-0.6381152221828302,0.9043478260869565,0.958727981794755,1.0,6/10,31.33%,APH1A;VSIR;APH1B;PSME3;PSME1;PSENEN
prerank,adenyl nucleotide binding (GO:0030554),0.29910294661216263,0.6313696171449297,0.9025110782865583,1.0,1.0,4/11,22.10%,BAG1;HSPH1;BAG4;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.29910294661216263,0.6313696171449297,0.9025110782865583,1.0,1.0,4/11,22.10%,BAG1;HSPH1;BAG4;SIL1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.29034281347889024,0.6297152993291716,0.8976945244956772,1.0,1.0,5/13,21.88%,GPSM1;GPSM2;ITGB1BP1;CCDC88A;GDI2
prerank,water transmembrane transporter activity (GO:0005372),0.28786858558690986,0.6277711468816787,0.9011627906976745,1.0,1.0,1/11,14.55%,AQP4
prerank,peptidase activator activity (GO:0016504),0.2608049714133847,0.6260745700320643,0.9159001314060446,1.0,1.0,3/22,10.21%,PCOLCE;VCP;PSME2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.26951334379905806,0.6260403852730088,0.9162234042553191,1.0,1.0,18/18,73.08%,RDH5;HSD3B1;HSD17B3;HSD17B6;RDH16;DHRS9;AKR1C1;HSD3B2;SRD5A2;HSD17B1;HSD17B14;HSD3B7;HSD17B2;HSD17B10;HSD11B1;HSD17B8;HSD17B7;DHRS11
prerank,neuropeptide receptor activity (GO:0008188),0.23904580539621834,0.6214732851836443,0.9325153374233128,1.0,1.0,2/29,8.05%,HCRTR2;GPR37
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23403866849303806,0.6182017681181462,0.9481743227326266,1.0,1.0,8/32,19.34%,KDM7A;KDM2B;ALKBH3;EGLN2;BBOX1;FTO;ALKBH1;TET1
prerank,voltage-gated ion channel activity (GO:0005244),0.27250332735581345,0.6152228644349308,0.8912732474964234,1.0,1.0,3/14,18.02%,VDAC2;VDAC1;PKD2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.26201422346551523,0.6111555600219065,0.9218106995884774,1.0,1.0,3/16,20.66%,SLC22A4;SLC44A2;SLC44A1
prerank,cyclic nucleotide binding (GO:0030551),0.25621847782780155,0.6109155867655108,0.9308093994778068,1.0,1.0,4/21,19.07%,PDE4A;PDE10A;PDE4B;KCNH1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.18495173475278348,-0.6109048871238419,0.9631336405529954,0.9697989465419621,1.0,9/24,35.66%,KCNJ2;ABCC9;KCNJ3;KCNK1;KCNJ12;KCNN3;KCNK6;KCNJ8;KCNJ15
prerank,lipoprotein particle receptor binding (GO:0070325),0.24279945633960562,0.6080608018820168,0.947103274559194,1.0,1.0,6/27,17.19%,LRPAP1;LANCL1;SYT1;LRP1;HSPG2;APOE
prerank,potassium ion leak channel activity (GO:0022841),0.2714434277002799,0.6076666557749218,0.9197183098591549,0.9996029471542737,1.0,1/15,5.33%,KCNK2
prerank,kinase activity (GO:0016301),0.2046325101398806,0.6070815290004465,0.9702564102564103,0.9979330532743347,1.0,27/109,22.67%,COQ8B;CDKL5;TAOK1;CDK5;DCAKD;ABL1;PANK4;COASY;PIK3CB;IPPK;PI4KB;CHKB;CKB;PIK3C2B;PIK3C3;IPMK;IP6K1;NEK1;PGK1;PAPSS1;DGKI;LYN;MAP4K4;TAF1;PSTK;NADK2;EPHA4
prerank,voltage-gated sodium channel activity (GO:0005248),0.2488730654253828,0.6018388112014078,0.9451530612244898,0.9992819560044129,1.0,3/22,10.99%,SCN7A;SCN2B;SCN1A
prerank,magnesium ion binding (GO:0000287),0.19952682294189286,0.5981223488906903,0.9918864097363083,0.9995382960948,1.0,27/135,20.40%,NUAK2;TKT;ABL1;PPA2;STK11;BRSK2;RAP2A;SIK1;DHX36;NUDT12;BRSK1;NUDT3;ENDOV;TDP2;HPRT1;GCLC;EYA2;EPHX2;DIS3L2;NT5C3A;TPPP;OXSR1;SRPK1;CDC42BPB;MTPAP;IMPA1;PDCD6
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.25138605258834856,0.5948330331466101,0.9206989247311828,0.9995021256169062,1.0,3/18,13.07%,PIK3R1;PIK3R2;WDR91
prerank,ADP binding (GO:0043531),0.23659599016685007,0.594122145903582,0.9434954007884363,0.9978365522508041,1.0,8/25,21.80%,MYH10;GCLC;PPP5C;PGK1;PRKAG2;ME1;ABCG1;MYH9
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.25740833751883463,0.5833086396319987,0.938288920056101,1.0,1.0,15/15,74.28%,SAP30L;LANCL2;SH3PXD2B;SESTD1;PLEKHA5;PLCZ1;OBSCN;VEPH1;RUBCNL;PHLDA3;SNX3;PLA2G4E;PLA2G4A;JPH2;PLEKHF1
prerank,sulfotransferase activity (GO:0008146),0.22060744407300004,0.5786842607041336,0.9712918660287081,1.0,1.0,2/33,6.08%,HS2ST1;CHST10
prerank,microtubule minus-end binding (GO:0051011),0.2624090677531366,0.5754214597204211,0.9497126436781609,1.0,1.0,4/13,22.15%,CAMSAP2;NUMA1;TUBGCP2;CAMSAP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.23654919648968145,0.5753711988374665,0.9555555555555556,1.0,1.0,5/22,17.19%,LRPAP1;LANCL1;SYT1;HSPG2;APOE
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2238866504840629,0.5724814895042863,0.969097651421508,0.9995608361543811,1.0,9/28,24.26%,PAK3;MAP2K2;RPS6KA1;MAP2K7;MAP2K3;MAP2K1;MAP2K6;SGK1;RPS6KA2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22292793648114057,-0.5716436455106003,0.9385113268608414,0.9827940075422489,1.0,2/11,7.18%,NUDT5;DCPS
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.20516157027570958,0.5673375266875837,0.9828962371721779,1.0,1.0,6/53,14.36%,SLC7A11;SLC38A9;SLC7A2;SLC25A38;SLC1A3;SLC1A5
prerank,miRNA binding (GO:0035198),0.2196374408295186,0.5670361511343441,0.9756394640682094,0.9981584945810251,1.0,9/30,22.97%,ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,sequence-specific mRNA binding (GO:1990825),0.27205951457375344,0.5654753001455255,0.9316770186335404,0.996903507119221,1.0,2/10,16.78%,SHFL;FMR1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.22080082366151618,0.5586082973025256,0.9671302149178256,0.9979570263100866,1.0,6/24,22.95%,ZDHHC3;GLUL;ZDHHC17;ZDHHC2;ZDHHC14;ZDHHC21
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21761169493591703,0.5565264204598143,0.9731051344743277,0.9969415368342412,1.0,5/28,16.21%,PRORP;ENDOV;AGO3;RPP30;NUDT16L1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.21068471939594918,0.5556419509809877,0.9797859690844233,0.9952991438326165,1.0,3/35,8.95%,ABL1;SRMS;TEC
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.263186571990137,0.5528949927487059,0.9479768786127167,0.9945224016827496,1.0,4/11,22.61%,DPAGT1;PTDSS1;PTDSS2;SAMD8
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.19038258276328515,0.5491233753680851,0.987012987012987,0.9940395531833855,1.0,5/69,7.58%,MOGAT3;CERS2;NMT1;SOAT1;ZDHHC3
prerank,FMN binding (GO:0010181),0.24458778372726098,0.5248999870117582,0.9672131147540983,1.0,1.0,1/11,6.76%,POR
prerank,chemokine activity (GO:0008009),0.20251516872050718,0.524190720507497,0.9864197530864197,0.9986814434889342,1.0,1/31,4.50%,CXCL12
prerank,myosin binding (GO:0017022),0.18032943563794182,0.5100767633619063,0.9966996699669967,1.0,1.0,12/55,22.42%,CXCR4;NCKIPSD;RAB10;RAB3B;MOBP;RAB8A;TRAK1;KIRREL1;RAB6A;GSN;LLGL1;RAB11B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.20655089355814832,0.5077688192516827,0.9748110831234257,0.9992757832150734,1.0,6/24,21.40%,AK4;AK5;AK3;IP6K1;CMPK1;AK1
prerank,potassium:proton antiporter activity (GO:0015386),0.23455968232395055,0.49442381377735956,0.962043795620438,1.0,1.0,4/10,25.80%,SLC9A7;SLC9A6;SLC9A9;SLC9A1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.1946363463194666,-0.4848104752941045,0.9879154078549849,0.9992537378640982,1.0,5/10,40.91%,B4GALT6;B4GALT7;B3GALT2;A3GALT2;B3GALT6
prerank,chemokine receptor binding (GO:0042379),0.18173824250504553,0.48275876126021466,0.9940828402366864,1.0,1.0,1/35,4.50%,CXCL12
prerank,BMP binding (GO:0036122),-0.18988130125916508,-0.4810437129216887,0.9900332225913622,0.994267327210214,1.0,1/11,7.61%,ENG
prerank,CCR chemokine receptor binding (GO:0048020),0.18831914195147276,0.4803815847769255,0.9914634146341463,0.999300985093511,1.0,6/28,26.05%,NARS1;CCL25;NES;CX3CL1;CNIH4;CCL14
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.20965489379516178,0.4735274002334434,0.9919028340080972,0.9985892229298661,1.0,2/14,13.55%,PRORP;RPP30
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.22069374950299428,0.47273448724328376,0.982274741506647,0.9967672319130433,1.0,1/11,12.11%,KCND3
prerank,protein phosphatase 1 binding (GO:0008157),0.19318882280915642,0.4612451979191282,0.9896907216494846,0.9965175134973813,1.0,3/21,17.75%,PPP1R9B;PPP1R16A;PPP1R11
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.19985341056389505,0.4337939481222842,0.9898697539797395,0.9977702461962202,1.0,6/12,26.90%,TENT5A;MTPAP;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.19508393551211722,0.4087255247934256,0.9924585218702866,0.9977375441270493,1.0,2/10,21.07%,DCLRE1A;EXD2
